A vision for safer food contact materials: public health concerns as
drivers for improved testing
Jane Munckea*, Anna-Maria Anderssonb, Thomas Backhausc, Scott M.
Belcherd, Justin M. Bouchera, Bethanie Carney Almrothc, Terrence J.
Collinse, Birgit Geuekea, Ksenia J. Grohf, Jerrold J. Heindelg, Frank A. von
Hippelh, Juliette Legleri, Maricel V. Maffinij, Olwenn V. Martink, John
Peterson Myerse,l, Angel Nadalm, Cristina Nerinn, Ana M. Sotoo, Leonardo
Trasandep, Laura N. Vandenbergq, Martin Wagnerr, Lisa Zimmermanna, R.
Thomas Zoellerq and Martin Scheringers*
a
Food Packaging Forum Foundation, Zurich, Switzerland; bDept. of Growth and
Reproduction, Rigshospitalet and Centre for Research and Research Training in Male
Reproduction and Child Health (EDMaRC), Copenhagen University Hospital –
Rigshospitalet, Copenhagen, Denmark, Copenhagen, Denmark; cDept of Biological and
Environmental Sciences, University of Gothenburg, Sweden; dDept. of Biological
Sciences, North Carolina State University, Raleigh, NC, USA; eDept. of Chemistry,
Carnegie Mellon University, PA, USA; fDepartment of Environmental Toxicology,
Eawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf,
Switzerland; gHealthy Environment and Endocrine Disruptor Strategies, Commonweal,
Durham, NC, USA; hMel & Enid Zuckerman College of Public Health, University of
Arizona, AZ, USA; iDept. of Population Health Sciences, Faculty of Veterinary
Medicine, University of Utrecht, Netherlands; jIndependent consultant, Frederick, MD,
USA; kPlastic Waste Innovation Hub, Department of Arts and Science, University
College London, England, UK; lEnvironmental Health Sciences, Charlottesville, VA,
USA; mIDiBE and CIBERDEM, Miguel Hernández University of Elche, Alicante, Spain;
n
Dept. of Analytical Chemistry, I3A, University of Zaragoza, Zaragoza, Spain;
o
Departent of Immunology, Tufts University School of Medicine, Boston, MA, USA and
Centre Cavaillès, Ecole Normale Supérieure, Paris, France; pCollege of Global Public
Health and Grossman School of Medicine and Wagner School of Public Service, New
York University, New York, NY, USA; qDepartment of Environmental Health Sciences,
School of Public Health & Health Sciences, University of Massachusetts Amherst,
Amherst, MA, USA; rDept. of Biology, Faculty of Natural Sciences, Norwegian
University of Science and Technology, Trondheim, Norway; sEnvironmental Chemistry
and Modelling, RECETOX, Masaryk University, Brno, Czech Republic and Department
of Environmental System Sciences, ETH Zurich, Switzerland
*corresponding authors: jane.muncke@fp-forum.org; scheringer@usys.ethz.ch
1
Abbreviations
AOP
Adverse Outcome Pathway
BPA
bisphenol A
CVD
Cardiovascular Disease
FCC
Food Contact Chemical
NCD
Non-Communicable Disease
NIAS Non-Intentionally Added Substance
PFAS Per- and polyfluoroalkyl Substances
PFOA perfluorooctanoic acid
SCOD Six Clusters of Disease
manuscript under review
2
A vision for safer food contact materials: public health concerns as
drivers for improved testing
Food contact materials and articles are ubiquitous in today’s globalized food
system. Chemicals migrate from food contact materials into foodstuffs, but
current regulatory requirements do not sufficiently protect public health from
hazardous food contact chemicals (FCCs) because only individual substances
used to make food contact materials are tested and mostly only for genotoxicity
while endocrine disruption and other hazard properties are disregarded. Indeed,
food contact materials are a known source of a wide range of hazardous
chemicals, and they likely contribute to highly prevalent non-communicable
diseases. Food contact materials can also include non-intentionally added
substances (NIAS), which often are unknown and therefore not subject to risk
assessment. To address these important shortcomings, we outline how the safety
of food contact materials may be improved by (1) testing the overall migrate,
including (unknown) NIAS, and (2) expanding toxicological testing beyond
genotoxicity to multiple endpoints associated with non-communicable diseases
relevant to human health. To identify mechanistic endpoints for testing, we group
chronic health outcomes associated with chemical exposure into Six Clusters of
Disease (SCOD) and we propose that finished food contact materials should be
tested for their impacts on these SCOD. Future research should focus on
development of robust, relevant and sensitive in vitro assays based on
mechanistic information linked to the SCOD, e.g., through Adverse Outcome
Pathways (AOPs) or Key Characteristics of Toxicants. Implementing this vision
will improve prevention of chronic diseases that are associated with hazardous
chemical exposures, including from food contact materials.
Keywords: food packaging; risk assessment; chronic disease; chemical safety
3
1. Introduction
In today’s globalized food system, food contact materials and articles such as
food packaging, tableware, and food processing equipment are ubiquitous, especially
those made of plastic (1, 2). This increases exposures to food contact chemicals (FCCs)
migrating from food contact materials (3-5). This widespread, continuous exposure to a
wide range of synthetic chemicals requires a more stringent safety assessment of food
contact materials than the current approaches used in both low- and high-income
countries (6-10).
Food contact materials have been studied for over 50 years and are a known
source of chemicals that migrate into foodstuffs (11-19). Numerous FCCs, either
intentionally used in the manufacture of food contact materials or non-intentionally
added substances (NIAS) that are present in the finished food contact material/article
and that migrate into foodstuffs (5, 20, 21), are known to be hazardous and implicated
with adverse human health impacts (22-29).
However, the current approach to chemical risk assessment for food contact
materials is largely focused on assessing genotoxicity of single substances used to
manufacture food contact materials and therefore fails to account for other highly
relevant mechanisms of toxicity that are of equal concern as genotoxicity (10) and, what
is more, the current approach does not assess NIAS that also migrate from food contact
materials (Fig. 1) (17, 30). Addressing both issues is feasible in a cost-efficient way and
necessary to protect public health.
Indeed, non-cancer non-communicable diseases (NCDs) of increasing
prevalence in the global human population have been associated with several widely
used FCCs, such as bisphenol A (BPA), bisphenol F, perchlorate, and di(2-ethyl hexyl)
phthalate (DEHP), to name a few (Table 1). Given that humans are in daily contact with
food contact materials, those materials are likely a relevant exposure source of
hazardous chemicals that contribute to various NCDs globally.
In this article, we outline an improved assessment scheme for hazard
identification of FCCs that captures all exposure-relevant chemicals including
(unknown) NIAS, and we present a vision for assessing the safety of food contact
materials that addresses biological effects linked to the most prevalent NCDs (31, 32).
These include heart disease, stroke, cancer, diabetes, reproductive disorders, and several
neurological conditions. We provide guidance on research and policy actions that
should be developed to protect the public from avoidable chronic chemical exposures
originating from food contact materials and articles.
4
Figure 1. Chemical risk assessment for food contact chemicals (FCCs): current
practice. The current approach for assessing the safety of FCCs focuses on testing single
substances that are intentionally used to make food contact materials. The toxicological focus is
on mutagenicity and genotoxicity, therefore only carcinogenicity is currently determined as a
human health relevant endpoint for predicting chronic disease. However, many more chemicals
can migrate simultaneously from the finished food contact material, including unidentified
compounds that are non-intentionally added substances (NIAS). The migrating mixture is
known as the overall migrate, and it can also exert adverse effects (mixture toxicity). Currently,
the assessment of overall migrate mixture toxicity is not legally required. Illustrator: Michael
Stünzi.
2. Problem set-up: Shortcomings of the current approach
2.1 Non-communicable diseases are increasingly prevalent and associated with
chemical exposures
NCDs are a significant contributor to global mortality (33). However, the impact
of NCDs is far greater than mortality alone, especially in low- and middle-income
countries. Both mortality and morbidity of selected NCDs have increased substantially
over the last 30 years. Premature deaths (<70 years) are primarily associated with
cardiovascular disease (17.7 million deaths per year, accounting for 45% of all NCD
deaths), cancer (8.8 million deaths per year, 22% of all NCD deaths), chronic
respiratory disease (3.9 million deaths per year, 10% of all NCD deaths) and diabetes
(1.6 million deaths per year, 4% of all NCD deaths) (33). Expressed in DisabilityAdjusted Life Years, cardiovascular diseases have increased by a factor of 1.4 from
1990 to 2017, neoplasms by a factor of 1.5, and diabetes, urogenital, blood and
endocrine diseases by a factor of 1.6 (from 1990 to 2016) (34) (Figure S1, Supplemental
Material). Furthermore, among reproductive-age women and men, infertility is now the
most prevalent chronic disease (35). Importantly, NCDs incur significant human
suffering in addition to their estimated economic costs (36-40), which further stresses
5
the need for urgent action towards prevention of morbidities associated with NCDs.
Chemical exposures are an important contributor to NCDs. Several well-studied
types of chemicals such as toxic metals, halogenated aromatics, and some pesticides
(41, 42), as well as some members of the endocrine disrupting compounds (43-47) are
associated with NCDs such as brain-related disorders, cancers, metabolic disorders and
cardiovascular disease. Specific FCCs such as BPA and several members of the orthophthalates group are associated with NCDs such as heart disease, diabetes, and some
forms of cancer (48, 49) (Table 1). Further, the effects of chemical exposures on risk of
NCDs are complex and multifaceted, with some outcomes occurring across generations
through transgenerational inheritance (47, 50, 51). It is also clear that these effects are
not limited to laboratory animals, as mixtures of chemicals including FCCs have been
associated with adverse health outcomes in prenatally exposed humans (46, 49, 52-55).
Table 1. Food contact chemicals (FCCs) associated with non-communicable diseases (NCDs)
from each of the Six Clusters of Disease (SCOD) (non-exhaustive and non-systematic
overview). Identification of FCCs was based on the Food Contact Chemicals database (FCCdb)
(24) and the database on migrating and extractable food contact chemicals (FCCmigex) (17).
This overview is not a complete list of FCCs that are associated with adverse health outcomes.
Systematic reviews are indicated with*. Cancer agents are classified by cancer site (125).
Disease Cluster
Example disease
References
Testicular cancer
Associated FCC
exposure
PFOA
Cancers
Kidney cancer
PFOA
(229, 231)
Breast cancer
PFOA
(232)
(229, 230)
(232)
Cardiovascular
diseases
Brain-related
disorders
Cardiovascular diseases: including
myocardial infarction, arrhythmias, dilated
cardiomyopathy, atherosclerosis, and
hypertension
Hypothyroid
Abnormal neurodevelopment
Attention Deficit Hyperactivity
Disorder/behavior
Lower Intelligence Quotient
Language delay
Metabolic and
endocrine diseases
Type-1 diabetes
Ortho-phthalates
BPA
(233-236)
Ortho-phthalates
(237)
BPA
(238)
Ortho-phthalates
(239)
Perchlorate
(239)
PFAS
(240)
Ortho-phthalates:
DEHP, DBP, BBP and
DEP
Lead, BPA, orthophthalates
Endocrine disrupting
chemical (EDC)
mixture (Orthophthalates)
EDC mixture
(241)
BPA, Ortho-phthalates,
PFAS
(242-244)
(46, 245)
(55)
(246)
6
Type-2 diabetes
Pre-diabetes and diabetes
BPA
(247-249)
PFOA
(250)
Ortho-phthalates
(241, 251,
252)
BPA
(237, 253,
254)
(255, 256)
Obesity (BMI, waist circumference)
Childhood Obesity
PFAS
BPA
Gestational diabetes
Ortho-phthalates
Antimony
Non-alcoholic fatty liver disease
Ortho-phthalates
EDC mixture
(257)
(258)
(259)
(260)
(261)
(262)
Immunological
disorders
Kidney damage
PFAS
PFAS: PFOS and
PFOA
Ortho-phthalates:
DEHP and BBzP
Melamine
Male infertility
BPA
(265)
Dibutyl phthalate
(266)
Ortho-phthalates: DBP,
BBP, DEHP, and DINP
DEHP
(241, 251,
267)
(268)
Immunosuppression
Childhood asthma
Reproductive
disorders
Semen quality
Female infertility (reduced follicular count)
(263)
(241)
(264)
7
NCDs that are increasingly prevalent in the human population and that are
associated with hazardous chemical exposures can be grouped into disease clusters. On
this basis, we developed the novel concept of Six Clusters of Disease (SCOD) (Figure
2). The six clusters are cancers, cardiovascular diseases, reproductive disorders, brainrelated disorders, immunological disorders, and metabolic diseases. The SCOD concept
provides a rationale for systematically assessing the safety of chemicals in food contact
materials, with a focus on the prevention of chemical-associated, highly prevalent, and
severe NCDs. As such, the SCOD concept expands current efforts for chemical risk
assessment of FCCs.
Figure 2. The novel Six Clusters of Disease (SCOD) concept comprises noncommunicable diseases (NCDs) that are highly prevalent in the global human population, of
increasing concern, and associated with hazardous chemical exposures that can be clustered by
disease type. They include cancers, cardiovascular diseases, reproductive disorders, brain
disorders, immunological disorders, and metabolic diseases. The SCOD are of major concern
for public health and require novel approaches for prevention, namely the identification of
chemical contributors. Chemical risk assessment of food contact chemicals (FCCs) should
determine contributions to diseases of public health concern. Preventing exposure to chemicals
in food contact materials that contribute to NCDs is critical for successful primary prevention
strategies. Illustrator: Michael Stünzi.
2.2 Current risk assessment of food contact chemicals is not sufficiently
protective of human health
The universe of known FCCs comprises at least 14,153 substances, and for at
least 1,518 FCCs empirical evidence for migration from food contact articles and
materials is publicly available (17). Evidence of human exposure exists for hundreds of
these chemicals (4, 55-66). At least 388 FCCs in use today are known to be
carcinogenic, mutagenic or toxic to reproduction, possess endocrine disrupting
properties, or have other properties of concern such as persistence (22).
Currently, in the United States (US), Canada, the European Union (EU), China
and other countries, chemical risk assessment is required for all migrating substances
(Figure 1). In practice, however, it is predominantly the intentionally used substances
that are assessed for their risk to human health. Humans are exposed to many more
FCCs that are non-intentionally added to the finished food contact material or foodstuff.
These NIAS include impurities of the starting substances, reaction by-products, or
degradation products of starting substances (like additives) (5, 67-69). NIAS most often
are unidentified, they are common in food contact materials with high chemical
complexity, and they are likely to be biologically active (70). Under the current
8
chemicals risk assessment paradigm for food contact materials, where a chemical’s
identity must be known, unidentified FCCs cannot be assessed, although, for example,
the EU plastic food contact regulation requires the risk assessment of NIAS (71), and
also US FDA’s Food Contact Notification has information requirements on impurities
and reaction by-products (72).
A second problem is the lack of testing of substances present in the finished
food contact material. Several approaches have been developed to approximate the
health risks of unknown NIAS (73-79), but these approaches contain substantial
uncertainties related to hazard estimation, chemical identification, and quantification
(80, 81) because they are based on assumptions that cannot be entirely supported by
empirical evidence. For example, generic thresholds for chronic exposures to
nongenotoxic carcinogens were derived from testing chemicals at maximum tolerable
doses (MTD) and at 1/2 MTD, but it depends on the exact mechanism by which a
chemical exerts its toxicity whether a low-dose extrapolation from MTD dosing is
appropriate or not (82, 83).
Finally, because some laws prohibit the use of chemicals that cause cancer in
humans or animals, testing methods currently focus on genotoxicity as a proxy for
predicting cancer risk (10, 84). This focus on genotoxic effects is at the expense of other
hazards, including outcomes relevant to other chronic NCDs. Thus, there is a need for
novel and more robust approaches to more fully evaluate all the relevant hazards to
human health associated with FCCs.
3. Our vision: to make safer food contact materials
3.1 Assessing toxicological effects relevant to the Six Clusters of Disease
Chronic exposure to hazardous chemicals is a known modifiable risk factor for
cancer and reducing exposure to hazardous or untested chemicals from consumer
products, including food contact materials, is a recommended preventive measure (85).
It is reasonable to assume that the same holds true for other NCDs that are associated
with chemical exposures, especially for endocrine disrupting chemicals (Table 1).
Indeed, exposure reductions can lower the incidence of disease (86), for example for
neurodevelopmental disorders (87), obesity (88) or male reproductive disorders (89).
NCDs that are increasingly prevalent in the human population and that are
associated with hazardous chemical exposures can be grouped into disease clusters. On
this basis, we have developed the novel concept of SCOD (Fig. 2). The SCOD concept
emerged from discussions with the Food Packaging Forum’s Scientific Advisory Board
(SAB) during several meetings between 2016 and 2022. The SCOD concept provides
for the first time a rationale for systematically assessing the safety of chemicals in food
contact materials, with a focus on the prevention of chemical-associated, highly
prevalent and severe NCDs. As such, the SCOD concept expands current efforts for
chemical risk assessment of FCCs beyond cancers induced via a genotoxic mechanism.
For each disease cluster within the SCOD, many widely used FCCs have been
associated with relevant diseases in both epidemiology and animal studies (Table 1).
For some, mechanistic evidence strengthens these associations. It is also this
mechanistic evidence that provides opportunities to use in silico and in vitro assays to
better map toxicity profiles of individual FCCs in finished food contact materials,
9
before they are placed on the market, as well as mixtures, extracts and migrates from
food contact materials and articles. The SCOD provides organizing principles for such
an approach.
3.2 Assessing real-life chemical exposures: testing overall migrate from food
contact materials
All FCCs that are relevant for human exposure should be tested, in other words,
FCCs used in the manufacturing of food contact materials should be tested as single
substances, and the real-life mixture of all migrating FCCs, the overall migrate, should
also be tested. In addition, the overall migrate should be subjected to non-targeted
chemical analyses that are aimed to identify its chemical composition, including NIAS
(90). This combined testing and chemical identification approach could inform the
development of safer food contact materials by selecting less hazardous ingredients and
developing manufacturing processes that generate fewer and less biologically active
NIAS. Such an approach would be aligned with the proposed Safe and sustainable by
Design criteria included in the EU’s Chemicals Strategy for Sustainability (91).
The already available as well as emerging in vitro assays provide an opportunity
to identify hazardous properties of single substances and of the overall migrate. In vitro
test systems are small-scale, often single-cell or small organism systems, for example
human cancer cell lines, bacteria, and fungi (e.g. yeast). Other high-throughput
screening assays utilize embryos and larvae from vertebrates such as zebrafish (Danio
rerio) or African clawed frog (Xenopus laevis). These assays can be performed
efficiently both in terms of time and cost and are usually based on mechanistic
pathways (92, 93).
Test batteries, where several relevant assays are combined simultaneously, can
also be operated as high-throughput screening methods such as those developed in
Tox21 and ToxCast (94-96), which demonstrate the feasibility of this approach. In this
way, diverse information about the interaction properties of a single chemical with
different biological systems can be generated efficiently, and with lower cost, compared
to whole-animal testing used in traditional toxicology.
These assessments should be guided by the SCOD concept. However, gaps exist
in the current understanding of molecular pathways related to the SCOD, and these in
vitro assays remain insufficient to identify the full panoply of potential hazards,
especially those mediated by endocrine mechanisms. In vitro assays included in highthroughput test batteries need to be appropriate for predicting relevant human health
outcomes; should be demonstrated to be reproducible, sufficiently specific and
sensitive; and must be executed transparently (97, 98). Because of the limited in vitro
assays for known pathways and mechanisms of action associated with endocrine
disruption and other complex biological cascades, animal testing needs to continue, but
at a reduced level than in the past. For example, no current in vitro approaches would
have revealed what is now known to be a feature of some chemical exposures, e.g.,
transgenerational epigenetic inheritance (99). Acknowledging these and other gaps, the
European Commission is funding EURION, a program to develop new testing and
screening methods (including many in vitro approaches) for identifying endocrine
disrupting chemicals (100).
10
3.3 Shifting from the status quo to a more comprehensive approach to testing
Within the SCOD, increasingly available mechanistic information enables an
understanding of how chemicals contribute to highly prevalent NCDs. Two emerging
frameworks are being implemented to describe how chemicals affect complex diseases
and to provide a more uniform approach to evaluating mechanistic evidence: the key
characteristics concept, and adverse outcome pathways (AOPs). Both offer
opportunities to shift from the status quo, modernize hazard assessments, and develop
suitable in vitro assays.
3.3.1 The Key Characteristics concept: modernizing chemical hazard assessments
The key characteristics concept makes use of information about the properties of
hazardous chemicals that have empirical evidence linking them causally to relevant
apical (disease) endpoints (101). The underlying premise is that chemicals that cause the
same disease outcomes in whole organisms share molecular properties (i.e., key
characteristics) that are relevant for their hazardous properties. The key characteristics
for different disease outcomes are hence defined using empirical evidence for wellcharacterized chemicals, combined from epidemiological, in vivo and mechanistic
studies. These disease-specific key characteristics can then be used to develop
mechanistic in vitro assays to screen chemicals for their propensity to contribute to
different disease clusters and thereby reduce the need for in vivo experiments while still
decreasing scientific uncertainty normally associated with in vitro data.
The key characteristics were first developed for carcinogens, drawing from
existing mechanistic information from thoroughly assessed chemicals that are known to
be carcinogenic in humans (101-105). Additional key characteristics of other diseasecausing chemicals have also been described, such as for hepatotoxicants (106),
endocrine disrupting chemicals (107), female reproductive toxicants (108), male
reproductive toxicants (109), cardiovascular toxicants (110), and immunotoxicants
(111). For metabolic toxicants and neurotoxicants, work to describe key characteristics
is ongoing. Taken together, the key characteristics approach provides an excellent
starting point for the mechanistic understanding of how certain chemicals are associated
with NCDs, such as those covered in the SCOD.
3.3.2 Using other mechanistic information to develop suitable in vitro assays
In addition to the key characteristics, further important mechanistic
understanding is becoming available and can be useful to inform development of
dedicated in vitro screening assays for hazard assessments of FCCs. Chemicals exert
toxic effects by combinations of many different molecular-level events. These
mechanistic events leading to apical endpoints of toxicity can be organized in an AOP
(112). Several AOPs relevant to NCDs in the SCOD have been proposed, such as
estrogen receptor activation leading to breast cancer (113) and the upregulation of
thyroid hormone catabolism (via activation of hepatic nuclear receptors) leading to
subsequent adverse neurodevelopmental outcomes in mammals, specifically the loss of
cochlear function (114).Thus, AOPs are an emerging approach to organize mechanistic
information so that molecular or cellular-level targets can be identified for developing
in vitro assays that are relevant to the SCOD.
3.3.3 The novel approach: A vision for safer food contact materials
11
Based on the presumption that mechanistic in vitro testing of chemicals supports
the prevention of NCDs within the SCOD, we propose a novel approach for testing
FCCs that
(1) covers individual FCCs as well as real-life mixtures, migrating (or extractable)
from finished food contact materials, including all known and unknown NIAS,
(2) assesses the health impacts of FCCs and real-life mixtures with respect to the
most prevalent NCDs in the human population, and
(3) evaluates effects that are upstream from the disease, relying on mechanistic
information and in vitro screening approaches (wherever possible) to accurately
predict health effects induced by FCCs and migrates.
This shift from current practice to the proposed approach is summarized in Fig. 3,
and a detailed overview is provided in Fig. 4. Our approach overcomes the most
challenging shortcomings of the current testing paradigm of chemical hazard
assessment of food contact materials, fully recognizing that to assess all adverse effects
of chemicals on biological systems, adequate in vivo testing is required, where
additional aspects would be addressed such as metabolic activation, unknown modes of
action leading to apical endpoints, and transgenerational effects. However, we also
realize that such extensive, multigeneration in vivo testing may not always be feasible
for various reasons, including ethical and practical ones. Therefore, we propose this
vision to improve FCC testing from the currently too limited scope towards a much
more comprehensive yet feasible approach that holds promise for better protection of
public health.
12
Figure 3. Schematic overview of the current vs. proposed approach to food contact
chemical (FCC) testing. Currently, single substances intentionally used to make food contact
materials are tested for genotoxicity using in vitro assays. The proposed new approach focuses
on testing the overall migrate (i.e., the human exposure-relevant mixture of all migrating FCCs)
for its potential to contribute to the Six Clusters of Disease (SCOD). Notably, single substances
used to make food contact materials would also be tested individually for the SCOD-relevant
endpoints and, if found to have biological activity, excluded from use in the manufacturing of
food contact materials. Illustrator: Michael Stünzi.
13
Figure 4. The vision for a novel approach to safety assessment of food contact
materials and articles. Finished food contact materials and articles are tested for their real-life
mixture of all migrating chemicals (the overall migrate), using in vitro screening assays as well
as non-targeted chemical analyses. The screening assays are mechanism-based and identify the
key characteristics, key initiating events, or other mechanisms of action of the overall migrate.
Screening assays are selected around the Six Clusters of Disease (SCOD) concept. In addition,
intentionally added substances used for the manufacture of food contact materials are also tested
as individual substances prior to their authorization, and the overall migrate is chemically
characterized using non-targeted approaches. Illustrator: Michael Stünzi.
4. Implementing the vision: assessing impacts of FCCs and relevant mixtures
on human health outcomes in the SCOD using mechanistic approaches
Here we review the mechanistic basis for each of the disease clusters included in
the SCOD, and selectively highlight available in vitro testing methods. Importantly,
some available assays cover key characteristics that are relevant for several disease
clusters.
This vision for expanded hazard assessment of food contact materials is based
on the finding that for each of the disease clusters included in the SCOD, some
mechanistic understanding is available for the way that chemicals cause disease (Table
2).
4.1 Cancer
As defined by Willis,
A neoplasm is an abnormal mass of tissue, the growth of which exceeds and is
14
uncoordinated with that of the normal tissues and persists in the same excessive
manner after cessation of the stimulus which evoked the change (115).
Regarding cancer causation, the somatic mutation theory posits that cancer is a
cellular disease caused by mutations of genes that disrupt the control of cell
proliferation. Yet, substantive contradictions exist between this theory and empirical
evidence (116), which inspired competing theories consider cancer as a problem of
tissue organization akin to organogenesis (117-119). Importantly, not all carcinogens
are mutagens (120) and, thus, carcinogenicity cannot be equated with genotoxicity. Yet,
because legal requirements restrict the use of cancer-causing agents in food contact
materials, testing of FCCs has focused on genotoxicity as a proxy to identify
carcinogenic substances.
Both carcinogens and mutagens are found in food contact materials including 1)
formaldehyde, a known human carcinogen (121), which migrates from various plastics
including melamine-formaldehyde plastics used as tableware for children, and
polyethylene terephthalate plastic (PET) (122, 123); 2) antimony trioxide, which “is
reasonably anticipated to be a human carcinogen” (124) and “probably carcinogenic to
humans” (125), and it is used in the manufacture of PET, where antimony is found to
migrate into soft drinks (123, 126); and 3) per- and polyfluoroalkyl substances (PFAS)
are widely used in the manufacture of food contact materials as processing aids in
plastic and paper food contact material production (127, 128), and perfluorooctanoic
acid has limited evidence for testicular and kidney cancers in humans (129).
The key characteristics for carcinogens reveal that these chemicals can be
mutagens, but that there are numerous other common features for these agents as well
(101-105). Guyton and Schubauer-Berigan (2021) recommended the use of in vitro
assays based on the key characteristics to identify carcinogens in high-throughput
screening (105). Further, Rider et al. (2021) proposed methods to use the key
characteristics to test chemical mixtures and their propensity to affect cancer
development including in mixtures of chemicals with different key characteristics of
carcinogens (130). Approaches such as these will provide important information for
testing mixtures such as the overall migrate from finished food contact materials.
Methods for evaluating genotoxicity are readily available, validated, and trusted.
Chemicals are considered genotoxic if they damage the structure, information content,
or segregation of DNA, with mutagenicity (i.e. changes to the nucleotide sequence)
being a sub-type of genotoxicity (131).
These methods include:
•
•
•
Mutagenicity: The Ames test, based on bacterial reverse mutagenicity, is the
most employed test for mutagenicity (Organisation for Economic Co-operation
and Development (OECD) test guideline (TG) 471). A mammalian cell (mouse
lymphoma) gene mutation test (OECD TG 490) is also available (132)
Chromosomal aberration: Cultured mammalian cells are assessed for the
presence of chromatid-type and chromosome-type aberrations during metaphase
(OECD TG 473)
Micronucleus: Micronuclei represent chromosomal damage (chromosome
fragments or whole chromosomes) that have been transmitted to daughter cells.
Micronuclei can be assessed in vitro by using mammalian cells (OECD TG 487)
15
or in vivo with erythrocytes collected from bone marrow or peripheral blood
(OECD TG 874)
These methods are recommended or required for assessing intentionally used
FCCs (72, 133). Several other in vitro assays for assessing the genotoxic potential of
FCCs are also available (134). However, these strategies have not kept pace with
discoveries in cancer biology (135). Currently, no in vitro assays are available that
capture features of carcinogenicity beyond genotoxicity, but research is underway to
address this technical gap (136). On the other hand, the causal role of the
microenvironment in carcinogenicity, as put forward by tissue-based theories on
carcinogenicity (118), is not captured by such in vitro assays, because the reciprocal
interactions between stroma and parenchyma during development, regeneration, and
remodeling are not being considered (137). Although in vivo assays involving mammals
are available, traditional 2-year rodent carcinogenicity studies (OECD TG 451), either
alone or in combination with chronic toxicity studies, are rarely performed for FCCs.
4.2 Cardiovascular diseases
Cardiovascular diseases (CVDs) are a group of disorders arising due to
disfunction of the heart and blood vessels. The most recognized forms of CVD,
coronary heart disease and cerebrovascular disease, result in damage to tissues caused
by limited or complete loss of blood supply (138).
FCCs including several phthalates and bisphenols contribute to the causation of
CVDs, independent of obesity and diabetes (110). Bisphenols can disrupt calcium
signalling in myocardium and vasculature; and phthalates and bisphenols are oxidant
stressors that accelerate coronary and other arterial inflammation (110). In the US alone,
100,000 premature deaths from CVD among 55–64-year-olds each year are attributed to
exposure to one phthalate, DEHP (139). Other FCCs, such as antimony, may also
impair cardiovascular function and accelerate CVDs (140).
Lind et al. (2021) compiled the key characteristics of cardiovascular toxicants
and provided a comprehensive overview of robust and sensitive in vitro, ex vivo and in
vivo assays that are available for measuring dysregulation of Ca2+ ion homeostasis and
resulting arrhythmogenic activities of chemicals. For example, the increased risk for
CVDs associated with higher exposures to BPA is mechanistically associated with Ca2+
release and reuptake resulting in proarrhythmic delays after depolarizations in isolated
cardiomyocytes. BPA promotes Ca2+-mediated arrhythmias ex vivo in the whole heart
of rats and mice (141). However, this is only one of many possible mechanisms for
inducing CVDs, and further assay development is required.
Although several FCCs have been associated with CVDs, cardiovascular
toxicity is generally not evaluated for FCCs, whether they are intentionally used to
make food contact materials or NIAS present in finished food contact materials. This is
in part due to a reliance on in vivo guideline testing of general toxicity for chemicals
migrating at very high levels and limited to assessment of neoplastic and non-neoplastic
cardiac lesions in rodent models, which can be confounded by a high incidence of
background pathology in many of the rodent strains used for toxicity testing (142).
However, these are insensitive apical endpoints that only identify highly cardiotoxic
chemicals that result in robust pathology but miss subtle molecular effects (143, 144).
16
We recommend that comprehensive testing for all new chemicals include in
vitro and in silico testing harmonized with the Comprehensive in vitro Proarrhythmia
Assay approach (145, 146).
4.3 Brain-based disorders
Disrupted neurodevelopment can have numerous consequences including a
lower intelligence quotient, delayed language acquisition, ADHD, and autism (53, 55,
147). Because the role of thyroid hormone in brain development is well established,
hypothyroidism, especially during early development, is also a condition of concern
upstream of neurodevelopmental disorders. Neurotoxicity can also result from impaired
neuronal function due to a variety of factors, such as neuronal misplacement during
development, altered synapses, hypomyelin, or degeneration. Other neurodegenerative
conditions that typically arise later in life include Parkinson’s disease, Alzheimer’s
disease, and other forms of dementia.
The role of FCCs in the causation of many brain-based disorders is well
established, with substantial contribution to the burden of disease for both
neurodevelopmental and neurodegenerative disorders (37). For example, FCCs that
interfere with thyroid hormone systems or sex steroids (e.g., phthalates and perchlorate)
can affect brain development as well as cognitive function in adults (87, 148). The
vulnerability of the developing brain and the lack of systematic assessment of
neurodevelopmental toxicity for FCCs raises serious concerns (149). At present, the key
characteristics of neurotoxicants remain undescribed, but relevant work is ongoing.
In addition to assays covering interference with the thyroid and sex steroid axes,
in vitro testing of neurotoxicants requires sophisticated and reliable models due to the
complexity of the brain. Neuronal cell lines, primary central nervous system cells,
transformed neuronal precursors and stem cell derived progenitor cells are used in
neurotoxicity assays (150) to evaluate endpoints including migration, synapsis
formation, network activity and differentiation. Although single-cell cultures are
informative, multi-cell type and three-dimensional models utilizing microfluidics more
adequately represent the diversity and spatial properties of the brain (151-154), but high
throughput versions of these methods are not yet available, and thus their use in
evaluating FCCs has been limited. Additional in vitro assays for chemical screening of
neurotoxicants are under development in EU-funded research programs (155) and
research is ongoing to develop further in vitro assays targeting the thyroid system (156).
Recently, the establishment of a human cell-based in vitro battery has been reported; it
combines 10 assays selected to cover major key events in the relevant AOPs (157) and
was shown to provide 82% sensitivity in that it was able to identify 24 out of 28 known
neurotoxicants (158).
New low- and medium-throughput screening assays have been developed. For
example, the nematode is a promising model for evaluating known neurodevelopmental
toxicants and could be expanded to profiling chemicals with unknown neurotoxicity
(159, 160). Spontaneous movements (161), number and location of neurons (162), and
behavioral effects (163) are some of the neurological endpoints measured in zebrafish.
Validated high-throughput screening assays using African clawed frog tadpoles are also
available (OECD TG 248).
17
In vivo testing in rodents can be used to assess different functional aspects of
neurotoxicity including impacts on cognition, learning and memory; and anxiety-like,
depressive-like and reproductive behaviors. OECD developmental neurotoxicity
(OECD TG 426) and extended one-generation reproductive toxicity assays (OECD TG
443) include optional measurements of learning and memory, motor and sensory
function, motor activity, and auditory startle. Neurodegeneration is not covered because
animals are not kept until the end of their lifetime (164).
4.4 Obesity and Metabolic diseases
Metabolic diseases, including obesity, involve the many tissues that comprise
the metabolic system (165). These include adipose tissue, skeletal muscle, pancreas,
liver, gastrointestinal tract, bone, and brain. Type-2 diabetes, an important metabolic
disease with increasing prevalence in human populations, occurs due to systemic insulin
resistance, often with an increasing production of insulin by the pancreas. Type-1
diabetes occurs due to a progressive loss of β-cell insulin secretion. Non-alcoholic fatty
liver disease is another metabolic disease with increasing prevalence in human
populations.
While poor diet and insufficient physical activity are considered the chief drivers
of the obesity and diabetes twin pandemics, chemical exposures (for example, to
phthalates, bisphenols, parabens, PFAS, etc.) can disrupt the balance between energy
expenditure and energy intake (166). A large comprehensive review of metabolic
disrupting chemicals, including those that can induce obesity (obesogens), provides
strong evidence that numerous FCCs are associated with type-2 diabetes, obesity, and
fatty liver disease (167). The key characteristics of metabolic disruptors and obesogens
are being compiled. Rusyn et al. (2021) have described the key characteristics of acute
and chronic human hepatotoxicants and note that only one of 12 key characteristics are
specific to liver tissue (KC9: causing cholestasis) (106).
The simplest assays to identify an obesity hazard are those that measure the
effect of chemical exposures on the development of adipocytes (168-170). Primary
preadipocyte cultures, or mesenchymal stem cell assays, use animal or human cells to
assess proliferation and differentiation into adipocytes (169, 171-176), and a recent
study found that around one third of tested food contact articles contained metabolic
disrupting chemicals (177). Recently, spheroid adipocyte models have been developed
that improve the efficiency and speed of differentiation (178) and can be used for a
more comprehensive understanding of adipocyte physiology than monolayer cultures.
Other non-adipocyte cell lines, when well characterized, are also useful for mechanistic
studies (97, 179). In addition to adipocyte differentiation, several other mechanisms are
implicated with metabolic disease causations, for example the disruption of energy
homeostasis at the level of the hypothalamus and brain. Therefore, in vitro assays that
examine effects on hypothalamic neurons are useful (180, 181).
No assays have been developed to identify metabolic disruptors acting as
diabetogens. Ongoing projects are developing assays to measure β-cell function and
survival (182-184) using rodent β-cell lines (INS-1E and MIN-6) and a human β-cell
line (ENDOC-βH1). Assays of insulin function on the human liver cell line HepaRG,
the skeletal muscle cell line C2C12, and adipocytes are also under investigation (183).
One well established system of assays employing both in vitro and in vivo methods has
18
been used to explore the relationship between BPA and type-2 diabetes (185).
The most used assay to screen chemicals for effects on the liver uses the
HepaRG cell line. This cell line can be customized with different expression levels of
various drug metabolizing enzymes (186). Other 2D and 3D in vitro approaches use
primary hepatocytes (187) and other liver models (188) to screen for effects on liver
outcomes.
4.5 Immunological disorders
The immune system is an intricate network of many different, highly specialized
cells interacting with each other and with the nervous and endocrine systems (189).
Disorders of the immune system include autoimmune disorders such as multiple
sclerosis, Graves’ and Hashimoto’s diseases, lupus, Celiac’s, Addison’s, and
rheumatoid arthritis, among others. Other diseases including type-1 diabetes and asthma
have an important immune component. Therefore, assays for immunotoxicity need to
capture a multitude of potential effects, including immunosuppression,
immunostimulation, hypersensitivity reactions, mechanisms of autoimmunity, and
developmental immunotoxicity, e.g., delayed immunotoxic responses to toxic
influences (190).
The human immune system is highly effective, but also sensitive to synthetic
chemical insults during development and adult life. Effects of chemicals on the immune
system are less well understood in humans than other disease endpoints, but emerging
evidence implicates PFAS exposure in reducing immune response to vaccines and
increasing susceptibility to infections in early life (191). Other FCCs including
bisphenols and phthalates increase the risk of atopy and asthma (192-194), and
infections in early life (195).
The key characteristics of immunotoxicants have been described (111). This
offers a starting point for development of suitable in vitro assays for testing FCCs for
immunotoxicity. Due to the complexity of the immune system components and
responses, a comprehensive battery of in vitro assays covering all relevant aspects of
immunotoxicity has not been established. However, several in vitro assays, dealing for
example with direct immunosuppression, allergic hypersensitivity, or autoimmunity, are
being developed to detect a range of immunotoxicants (196-199) and these assays could
be used to screen FCCs (200).
4.6 Reproductive disorders
In industrialized countries, male reproductive health has declined over the past
decades, including a 50-60% decrease in sperm counts since 1973 (201, 202) and an
increase in testicular cancer (203). Female fertility is also affected, as are maternal
health and pregnancy outcomes, and conditions such as polycystic ovary syndrome
(PCOS), endometriosis, and premature ovarian failure (204).
The sperm count decrease is associated with chemical exposures (to, e.g.
phthalates), especially during fetal development (205). Strong evidence from animal
experiments support this interpretation (43, 206-208). FCC exposures are also
associated with PCOS (209), and other aspects of reproductive toxicity (210, 211).
These adverse outcomes have even been found for FCCs promoted as safer alternatives
19
to hazardous chemicals such as the plasticizer 1,2-cyclohexane dicarboxylic acid
diisononyl ester (tradename Hexamoll DINCH) (212), which is used as a replacement
for DEHP and other phthalates. Several FCCs such as BPA have been studied for
mechanistic-level impacts on female fertility, including oogenesis, folliculogenesis, and
altered expression of gonadotropin and gonadotropin hormone-releasing hormone
receptors (213). The key characteristics of male (109) and female reproductive toxicants
(108) have been described. Development and function of the reproductive system is
fundamentally dependent on sex hormone action. Thus, the key characteristics of
endocrine disrupting chemicals (114) are also relevant to the study of chemicals that
affect reproductive outcomes. However, a systematic overview of available in vitro
assays for hazard identification of endocrine disrupting chemicals that affect male and
female fertility is unavailable.
In vitro assays that identify chemical interference with sex hormone production
and signalling have been validated (OECD TG 493, 455, 458, 456). These include
assays based on nuclear receptor activation and steroid hormone synthesis. The bovine
oocyte maturation assay (ECVAM TM 2010-05) is also a reproduction-relevant in vitro
assay. A good correlation between in vitro results and in vivo observations has been
established for female fertility endpoints (214, 215). Validated in vivo assays exist to
evaluate reproductive toxicity for impacts on both male and female fertility (OECD TG
443), but these may not be sufficiently sensitive or comprehensive.
Table 2. Examples of food contact chemicals (FCCs) that are associated with diseases from the
Six Clusters of Disease (SCOD) by mechanisms from in vitro and/or in vivo studies. Not a
complete list: Select references only.
Disease Cluster
Food Contact Chemical
Reference
Cancers
Melamine (CAS 108-78-1)
(269)
Cardiovascular
diseases
Brain-related
Formaldehyde (CAS 50-00-0)
(121)
Benzidine (CAS 92-87-5)
(270)
4,4′-Diamino-3,3′ Dichlorodiphenylmethane (MOCA) (CAS 101-14-4)
Antimony trioxide (CAS 1309-64-4)
(121)
Perfluorooctanoic acid (PFOA) (CAS 335-67-1)
(272-274)
Di (2-ethylhexyl) phthalate (DEHP) (CAS 117-81-7)
(275, 276)
Bisphenol A (BPA) (CAS 80-05-7)
(277-280)
Bisphenol A (BPA) (CAS 80-05-7)
Triclosan (CAS 3380-34-5)
(143, 281285)
(284)
Tributyltin chloride (CAS 1461-22-9)
(284)
Diethanolamine (CAS 111-42-2)
(286)
DEHP
(287)
Perchlorate (CAS 14797-73-0)
(288)
(271)
20
(289)
disorders
Metabolic diseases
Immunological
disorders
Reproductive
disorders
Ortho-phthalates
BPA
(290, 291)
Bisphenol S (BPS) (CAS 80-09-1)
(290, 292)
BPA
(293-297)
Bisphenol A diglycidyl ether (BADGE) (CAS 167554-3)
Organotins
(298)
Perchlorate
(300)
Perfluorooctanesulfonic acid (PFOS) (CAS 1763-231)
Bisphenol F (BPF) (CAS 620-92-8)
(301, 302)
BPS
(303)
2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD;
Surfynol) (CAS 126-86-3)
DEHP
(304-306)
Melamine
(269)
BPA
(290)
BPF
(290)
BPS
(290, 308)
2,4-di-tert-butylphenol (CAS 96-76-4)
(309)
DEHP
(308, 310)
BPA
(311-314)
BADGE
(298, 306)
BPS
(315)
DEHP
(287, 312)
(299)
(303)
(297, 307)
21
5. What is needed to implement the vision for safer food contact materials?
To achieve our vision, we propose a multi-pronged approach that is grounded in
the SCOD concept, which includes many of the most prevalent NCDs of high relevance
to human health. We identified three components needed to realize this vision:
analytical methods and testing strategies, data integration and interpretation, and science
to inform decision making.
5.1 Analytical methods and testing strategies
In Section 4 we list several available and emerging assays used in the
identification of hazard for each of the SCOD. However much more is needed,
especially high-throughput non-animal and low-medium throughput assays with nonmammalian models. These assays would overcome challenges with cost, time, and
scientific relevance as the selection of suitable in vitro assays would be based on robust
mechanistic evidence from key characteristics and AOPs. Identification of the key
characteristics for brain disorders and metabolic diseases will form the basis for
identification and/or development of relevant in vitro assays to identify hazardous
chemicals related to these clusters. For in vitro testing based on mechanistic pathways
to succeed, additional dedicated expertise and financial support are needed to identify
assays that would address relevant key characteristics. This work is ongoing and the
website keycharacteristics.org collates all available information and publications in this
area (216).
Another important aspect of testing is the development and validation of
methods that reflect real-world chemical exposures from food contact materials.
Migration testing protocols exist but ongoing research efforts need to be expanded and
validated to ensure minimal loss of potentially hazardous chemicals during sample
preparation (e.g. by using polar and apolar food simulants and by capturing not only
non-volatile compounds, but also those that are semi-volatile and volatile).
Lastly, a battery of screening assays addressing the SCOD needs to be defined
and validated. This step will need the contribution of experts in each field to ensure that
the selected endpoints are reliable and result in high confidence.
5.2 Data interpretation and integration
Methods must be developed to interpret and corroborate in vitro test results.
Individual assays should be integrated into an overall high-level / aggregated scheme
(e.g. using visualization approaches such as ToxPi (217, 218)). Also, non-targeted
chemical analysis needs advancing to allow for better identification of currently
unknown compounds, especially when present at low concentrations. One way to
improve the latter is to create comprehensive and open mass spectrometry libraries of
FCCs, including NIAS. Ideally, an open-access repository of information about food
contact material manufacturing processes and the major FCCs associated with specific
materials should be generated. Confidential business information poses a critical
obstacle, as the full disclosure of the chemical composition of food contact materials is
commonly not available. Accordingly, a mechanism needs to be developed that enables
such an FCC library without infringing on intellectual property rights.
22
5.3 Science for decision making
The results of testing single chemical or overall migrate from a food contact
material using a battery of assays for each of the SCOD would need to be interpreted
and integrated with available evidence to reach a conclusion within a regulatory context.
A framework, similar to that available for read-across (219, 220), should be developed
to effectively utilize results and support conclusions that are actionable for policy
makers and regulatory enforcement. The experience gained from development of effectbased trigger values for water quality assessment in Europe could be highly informative
(221, 222). Here, effect-based trigger values have been developed as a means to
interpret the results of in vitro assays through linking the existing water quality
guideline values to observed levels of bioactivity elicited by a reference chemical. Then,
if a test chemical or mixture causes an activity above the trigger value set for a specific
assay, it is highlighted for a follow-up assessment, such as calculation of concentration
factors and in vitro to in vivo extrapolation (223-225). In theory, effect-based trigger
values for food contact materials could be developed following the same principle, e.g.
by matching effect concentrations in relevant bioassays with existing specific migration
limits for FCCs of concern, and possibly factoring in additional exposure-related
parameters. This approach appears highly promising, since it has been demonstrated
that derivation of effect-based trigger values greatly facilitates regulatory and practical
uptake of in vitro methods into specific assessment pipelines (222).
6. Conclusion
The novel approach we present here is in line with the goals laid out in the EU’s
Chemicals Strategy for Sustainability (91), the EU Farm to Fork Strategy (226), and the
European Parliament’s report on food contact materials (227), which emphasize the
need for revising food contact material regulation in Europe to adequately reflect recent
scientific understanding and improve compliance. Further, this work adds to previous
publications on policies and methods related to the risk assessment of food contact
chemicals and materials (10, 22, 30).
We think that our vision to create safer food contact materials by linking hazard
identification more directly to human health has the potential to spur innovation in assay
development and testing, and ultimately, for safer materials as such. Additionally, new
findings on the key characteristics for the NCDs included in the SCOD, as well as
mechanistic understanding derived from AOP research, will support the development of
new assays.
Awareness of adverse health effects of synthetic chemicals is increasing globally,
and the need is obvious for significant and urgent improvements in the ways that risks
are assessed and managed for FCCs (228).
Acknowledgements
We are grateful to Michele La Merrill for constructive comments on this manuscript.
23
Declarations
Competing Interests
The authors have no competing interests to declare. For the sake of transparency, the
authors list their relationships with various research funders and not-for-profit
organizations in the following. As researchers employed by the Food Packaging Forum
Foundation (FPF) (JMB, BG, JM, LZ) or working pro bono as members of the
Foundation’s board (TB, JPM, MS) and its Scientific Advisory Board (SAB) (AMA,
TJC, KJG, JJH, MVM, OVM, AN, CN, AMS, LT, MW, RTZ), we are reporting that the
FPF receives donations from diverse companies that may be affected by the research
reported in the enclosed paper. FPF funders have no influence on any of the work at
FPF and were not involved in any way in the preparation of this manuscript. TB
declares that he serves as the board member of the International Panel on Chemical
Pollution (IPCP), the Swedish Toxicological Council and the EU Commission’s
Committee on Health, Environmental and Emerging Risks (SCHEER). All those
activities are pro bono and have no bearing on the content of the manuscript. None of
the aforementioned organizations have had any impact on the content of the manuscript.
TJC declares that he is the creator-founder of Sudoc, LLC, which deploys TAML
catalysts for many applications and has potential for remediating FCCs in water. JL
reports that she receives funding for another research project (ZonMw/Health-Holland
Microplastics and Health project MOMENTUM 458001101) of which some partners
may be affected by the research reported here. MVM is a paid consultant to the FPF.
OVM is one of the representatives of the European Parliament on the European
Chemical Agency’s Management Board. JPM is co-founder and board member of
Sudoc and he declares to have given all his shares to an irrevocable grantor trust so that
he will not benefit financially if the company is successful. AN declares to have
received travel reimbursement from universities, NGOs and scientific societies, to speak
about endocrine-disrupting chemicals. LNV has received travel reimbursements from
universities, governments, NGOs, and industry. She has received research funding from
the US National Institutes of Health, the University of Massachusetts Amherst, and
NGOs including the Cornell Douglas Foundation, the Allen Family Foundation, and the
Great Neck Breast Cancer Coalition. She is a scientific advisor to Sudoc LLC. The FPF
foundation board, whose members have no connection with any of the FPF’s funders
and receive no remuneration for their work, is legally obliged to guarantee that the work
of the FPF is in no way influenced by the interests or views of the funders.
Authors’ contributions
This manuscript was initiated by the FPF’s SAB and guests participating in SAB
meetings in 2017, 2018, 2019, 2020, 2021; AMA, MVM, JM, JPM, RTZ and MS were
responsible for preparing an outline and a first version; JM, LVM, MVM and MS edited
the final draft, and all authors contributed to the various intermediate versions, wrote
separate sections of the manuscript, and approved the final version.
Funding
This work was supported by the FPF’s own resources. FPF is a charitable foundation
and it funded four meetings of its SAB with external scientific experts as guests (SMB,
24
BCA, FAvH, JL, LNV) during which this manuscript was prepared. Funding for travel
and accommodation was provided for three meetings and two additional meetings were
held online. Neither FPF’s SAB members nor guest participants were reimbursed for
their contributions to this manuscript. FPF’s funding sources are declared on its website
(https://www.foodpackagingforum.org/about-us/funding). MS acknowledges funding by
the CETOCOEN PLUS project (CZ.02.1.01/0.0/0.0/15_003/0000469), the project
CETOCOEN EXCELLENCE (CZ.02.1.01/0.0/0.0/17_043/0009632), and RECETOX
RI (LM2018121) financed by the Czech Ministry of Education, Youth and Sports.
Availability of data and materials
Not applicable.
References
1.
Chakori S, Aziz AA, Smith C, Dargusch P. Untangling the underlying drivers of the use of
single-use food packaging. Ecological Economics. 2021;185:107063.
2.
Poças MFF, Oliveira JC, Pinto HJ, Zacarias ME, Hogg T. Characterization of patterns of food
packaging usage in Portuguese homes. Food Addit Contam, Part A 2009;26(9):1314-24.
3.
Biryol D, Nicolas CI, Wambaugh J, Phillips K, Isaacs K. High-throughput dietary exposure
predictions for chemical migrants from food contact substances for use in chemical prioritization. Environ
Int. 2017;108:185-94.
4.
Koch HM, Calafat AM. Human body burdens of chemicals used in plastic manufacture. Philos
Trans R Soc Lond B Biol Sci. 2009;364(1526):2063-78.
5.
Qian S, Ji H, Wu X, Li N, Yang Y, Bu J, et al. Detection and quantification analysis of chemical
migrants in plastic food contact products. PloS one. 2018;13(12):e0208467.
6.
Neltner TG, Alger HM, Leonard JE, Maffini MV. Data Gaps in Toxicity Testing of Chemicals
Allowed in Food in the United States. Reproductive Toxicology. 2013(0).
7.
Maffini MV, Alger HM, Olson ED, Neltner TG. Looking Back to Look Forward: A Review of
FDA's Food Additives Safety Assessment. Comprehensive reviews in food science and food safety.
2013;12(4).
8.
Alger HM, Maffini MV, Kulkarni NR, Bongard ED, Neltner T. Perspectives on How FDA
Assesses Exposure to Food Additives When Evaluating Their Safety: Workshop Proceedings.
Comprehensive Reviews in Food Science and Food Safety. 2013;12(1):90-119.
9.
Grob K, Biedermann M, Scherbaum E, Roth M, Rieger K. Food contamination with organic
materials in perspective: packaging materials as the largest and least controlled source? A view focusing
on the European situation. Crit Rev Food Sci Nutr. 2006;46(7):529-35.
10.
Muncke J, Backhaus T, Geueke B, Maffini MV, Martin OV, Myers JP, et al. Scientific
challenges in the risk assessment of food contact materials. Environ Health Perspect.
2017;125(9):095001.
11.
Castle L, Mayo A, Crews C, Gilbert J. Migration of Poly(ethylene terephthalate) (PET)
Oligomers from PET Plastics into Foods during Microwave and Conventional Cooking and into Bottled
Beverages. J Food Prot. 1989;52(5):337-42.
12.
Bradley EL, Driffield M, Harmer N, Oldring PKT, Castle L. Identification of potential migrants
in epoxy phenolic can coatings. Int J Polym Anal Charact 2008;13(3):200-23.
25
13.
Dionisi G, Oldring PK. Estimates of per capita exposure to substances migrating from canned
foods and beverages. Food Addit Contam. 2002;19(9):891-903.
14.
Jickells SM, Gancedo P, Nerin C, Castle L, Gilbert J. Migration of styrene monomer from
thermoset polyester cookware into foods during high temperature applications. Food Addit Contam.
1993;10(5):567-73.
15.
Sanchis Y, Yusà V, Coscollà C. Analytical strategies for organic food packaging contaminants.
Journal of Chromatography A. 2017;1490:22-46.
16.
Nerin C, Asensio E. Migration of organic compounds from a multilayer plastic-paper material
intended for food packaging. Analytical and Bioanalytical Chemistry. 2007;389(2):589-96.
17.
Geueke B, Groh KJ, Maffini MV, Martin OV, Boucher JM, Chiang Y-T, et al. Systematic
evidence on migrating and extractable food contact chemicals: Most chemicals detected in food contact
materials are not listed for use. Critical Reviews in Food Science and Nutrition. 2022:1-11.
18.
Tsochatzis ED, Lopes JA, Gika H, Dalsgaard TK, Theodoridis G. A fast SALLE GC–MS/MS
multi-analyte method for the determination of 75 food packaging substances in food simulants. Food
Chemistry. 2021;361:129998.
19.
Oldring PKT, Castle L, O’Mahony C, Dixon J. Estimates of dietary exposure to bisphenol A
(BPA) from light metal packaging using food consumption and packaging usage data: a refined
deterministic approach and a fully probabilistic (FACET) approach. Food Additives & Contaminants:
Part A. 2014;31(3):466-89.
20.
Nerin C, Alfaro P, Aznar M, Domeño C. The challenge of identifying non-intentionally added
substances from food packaging materials: A review. Analytica Chimica Acta. 2013;775(2 May
2013):14-24.
21.
Tisler S, Christensen JH. Non-target screening for the identification of migrating compounds
from reusable plastic bottles into drinking water. Journal of Hazardous Materials. 2022;429:128331.
22.
Zimmermann L, Scheringer M, Geueke B, Boucher JM, Parkinson LV, Groh KJ, et al.
Implementing the EU Chemicals Strategy for Sustainability: The case of Food Contact Chemicals of
Concern. Journal of Hazardous Materials. 2022:129167.
23.
Groh KJ, Geueke B, Martin O, Maffini M, Muncke J. Overview of intentionally used food
contact chemicals and their hazards. Environment international. 2021;150:106225.
24.
Groh KJ, Geueke B, Martin O, Maffini M, Muncke J. Overview of intentionally used food
contact chemicals and their hazards. Environment international. 2020:106225.
25.
Van Bossuyt M, Van Hoeck E, Vanhaecke T, Rogiers V, Mertens B. Prioritizing Substances of
Genotoxic Concern for In-Depth Safety Evaluation Using Non-Animal Approaches: The Example of
Food Contact Materials. Altex-Alternatives to Animal Experimentation. 2019;36(2):215-30.
26.
Van Bossuyt M, Van Hoeck E, Vanhaecke T, Rogiers V, Mertens B. Printed paper and board
food contact materials as a potential source of food contamination. Regulatory Toxicology and
Pharmacology. 2016;81:10-9.
27.
Souton E, Severin I, Le Hegarat L, Hogeveen K, Aljawish A, Fessard V, et al. Genotoxic effects
of food contact recycled paperboard extracts on two human hepatic cell lines. Food Additives &
Contaminants: Part A. 2017:1-12.
28.
Bengtstrom L, Rosenmai AK, Trier X, Jensen LK, Granby K, Vinggaard AM, et al. Nontargeted screening for contaminants in paper and board food-contact materials using effect-directed
analysis and accurate mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk
Assess. 2016;33(6):1080-93.
26
29.
Symeonides C, Brunner M, Mulders Y, Toshniwal P, Cantrell M, Mofflin L, et al. Buy-nowpay-later: Hazards to human and planetary health from plastics production, use and waste. Journal of
Paediatrics and Child Health. 2021;57(11):1795-804.
30.
Muncke J, Andersson A-M, Backhaus T, Boucher JM, Carney Almroth B, Castillo Castillo A, et
al. Impacts of food contact chemicals on human health: a consensus statement. Environmental Health.
2020;19(1):25.
31.
Muncke J. Tackling the toxics in plastics packaging. PLOS Biology. 2021;19(3):e3000961.
32.
Zare Jeddi M, Hopf NB, Viegas S, Price AB, Paini A, van Thriel C, et al. Towards a systematic
use of effect biomarkers in population and occupational biomonitoring. Environment international.
2021;146:106257.
33.
WHO. Noncommunicable diseases. Fact sheet.
2018:http://www.who.int/mediacentre/factsheets/fs355/en/.
34.
Roser M, Ritchie H, Spooner F. Burden of disease https://ourworldindata.org/burden-of-disease:
OurWorldInData.org; 2021 [Available from: https://ourworldindata.org/burden-of-disease.
35.
WHO. Infertility: WHO; 2020 [Available from: https://www.who.int/news-room/factsheets/detail/infertility.
36.
Kassotis CD, Vandenberg LN, Demeneix BA, Porta M, Slama R, Trasande L. Endocrinedisrupting chemicals: economic, regulatory, and policy implications. The Lancet Diabetes &
Endocrinology. 2020;8(8):719-30.
37.
Attina TM, Hauser R, Sathyanarayana S, Hunt PA, Bourguignon J-P, Myers JP, et al. Exposure
to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.
Lancet Diabetes Endo. 2016;4(12):996-1003.
38.
Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, et al. Estimating
burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J Clin
Endocrinol Metab. 2015;100(4):1245-55.
39.
Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, et al. Burden of
disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated
analysis. Andrology. 2016;4(4):565-72.
40.
Obsekov V, Kahn LG, Trasande L. Leveraging Systematic Reviews to Explore Disease Burden
and Costs of Per- and Polyfluoroalkyl Substance Exposures in the United States. Exposure and Health.
2022.
41.
Bergman A, Andersson A-M, Becher G, van den Berg M, Blumberg B, Bjerregaard P, et al.
Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention
by toxicology journal editors. Environmental Health. 2013;12(1):69.
42.
Rojas-Rueda D, Morales-Zamora E, Alsufyani WA, Herbst CH, AlBalawi SM, Alsukait R, et al.
Environmental Risk Factors and Health: An Umbrella Review of Meta-Analyses. International Journal of
Environmental Research and Public Health. 2021;18(2):704.
43.
Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, et al. EDC-2: The Endocrine
Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews.
2015;36(6):E1-E150.
44.
Goralczyk K. A Review of the Impact of Selected Anthropogenic Chemicals from the Group of
Endocrine Disruptors on Human Health. Toxics [Internet]. 2021; 9(7).
27
45.
Demeneix BA, Slama R. Endocrine Disruptors: From the scientific evidence to human health
protection. European Parliament; 2019. Contract No.:
http://www.europarl.europa.eu/thinktank/fr/document.html?reference=IPOL_STU(2019)608866 .
Accessed 7 June 2019.
46.
Tanner EM, Hallerbäck MU, Wikström S, Lindh C, Kiviranta H, Gennings C, et al. Early
prenatal exposure to suspected endocrine disruptor mixtures is associated with lower IQ at age seven.
Environment international. 2020;134:105185.
47.
Chamorro-Garcia R, Diaz-Castillo C, Shoucri BM, Käch H, Leavitt R, Shioda T, et al. Ancestral
perinatal obesogen exposure results in a transgenerational thrifty phenotype in mice. Nat Commun.
2017;8(1):2012.
48.
Martínez-Ibarra A, Martínez-Razo LD, MacDonald-Ramos K, Morales-Pacheco M, VázquezMartínez ER, López-López M, et al. Multisystemic alterations in humans induced by bisphenol A and
phthalates: Experimental, epidemiological and clinical studies reveal the need to change health policies.
Environmental Pollution. 2021;271:116380.
49.
Svensson K, Tanner E, Gennings C, Lindh C, Kiviranta H, Wikström S, et al. Prenatal exposures
to mixtures of endocrine disrupting chemicals and children’s weight trajectory up to age 5.5 in the
SELMA study. Scientific Reports. 2021;11(1):11036.
50.
Walker VR, Boyles AL, Pelch KE, Holmgren SD, Shapiro AJ, Blystone CR, et al. Human and
animal evidence of potential transgenerational inheritance of health effects: An evidence map and stateof-the-science evaluation. Environment international. 2018;115:48-69.
51.
Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nature
Reviews Genetics. 2012;13(2):97-109.
52.
Kortenkamp A, Faust M. Regulate to reduce chemical mixture risk. Science.
2018;361(6399):224-6.
53.
Bornehag C-G, Engdahl E, Unenge Hallerbäck M, Wikström S, Lindh C, Rüegg J, et al. Prenatal
exposure to bisphenols and cognitive function in children at 7 years of age in the Swedish SELMA study.
Environment international. 2021;150:106433.
54.
Bornehag C-G, Kitraki E, Stamatakis A, Panagiotidou E, Rudén C, Shu H, et al. A Novel
Approach to Chemical Mixture Risk Assessment—Linking Data from Population-Based Epidemiology
and Experimental Animal Tests. Risk Analysis. 2019;39(10):2259-71.
55.
Caporale N, Leemans M, Birgersson L, Germain P-L, Cheroni C, Borbély G, et al. From cohorts
to molecules: Adverse impacts of endocrine disrupting mixtures. Science. 2022;375(6582):eabe8244.
56.
Barr DB, Silva MJ, Kato K, Reidy JA, Malek NA, Hurtz D, et al. Assessing human exposure to
phthalates using monoesters and their oxidized metabolites as biomarkers. Environ Health Perspect.
2003;111(9):1148-51.
57.
Calafat A, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary Concentrations
of Bisphenol A and 4-Nonylphenol in a Human Reference Population. Environ Health Perspect.
2005;113(4):391-5.
58.
Silva MJ, Slakman AR, Reidy JA, Preau JL, Jr., Herbert AR, Samandar E, et al. Analysis of
human urine for fifteen phthalate metabolites using automated solid-phase extraction. J Chromatogr B
Analyt Technol Biomed Life Sci. 2004;805(1):161-7.
59.
Correia-Sá L, Schütze A, Norberto S, Calhau C, Domingues VF, Koch HM. Exposure of
Portuguese children to the novel non-phthalate plasticizer di-(iso-nonyl)-cyclohexane-1,2-dicarboxylate
(DINCH). Environment international. 2017;102:79-86.
28
60.
Cortéjade A, Buleté A, Prouteau L, Chatti S, Cren C, Vulliet E. Development and optimisation
of home-made stir bar sorptive extraction for analysis of plastic additives: application in human urine.
Analytical Methods. 2017;9(23):3549-60.
61.
Pouech C, Kiss A, Lafay F, Léonard D, Wiest L, Cren-Olivé C, et al. Human exposure
assessment to a large set of polymer additives through the analysis of urine by solid phase extraction
followed by ultra high performance liquid chromatography coupled to tandem mass spectrometry. J
Chromatogr A. 2015;1423(Supplement C):111-23.
62.
Rudel RA, Gray JM, Engel CL, Rawsthorne TW, Dodson RE, Ackerman JM, et al. Food
Packaging and Bisphenol A and Bis(2-Ethyhexyl) Phthalate Exposure: Findings from a Dietary
Intervention. Environ Health Perspect. 2011;119(7):914-20.
63.
Susmann HP, Schaider LA, Rodgers KM, Rudel R. Dietary Habits Related to Food Packaging
and Population Exposure to PFASs. Environmental health perspectives. 2019;127(10):10.
64.
Isaacs KK, Wall JT, Williams AR, Hobbie KA, Sobus JR, Ulrich E, et al. A harmonized
chemical monitoring database for support of exposure assessments. Sci Data. 2022;9(1):314.
65.
Domínguez-Romero E, Komprdová K, Kalina J, Bessems J, Karakitsios S, Sarigiannis DA, et al.
Time-trends in human urinary concentrations of phthalates and substitutes DEHT and DINCH in Asian
and North American countries (2009–2019). Journal of exposure science & environmental epidemiology.
2022.
66.
Bil W, Govarts E, Zeilmaker MJ, Woutersen M, Bessems J, Ma Y, et al. Approaches to mixture
risk assessment of PFASs in the European population based on human hazard and biomonitoring data.
International Journal of Hygiene and Environmental Health. 2023;247:114071.
67.
Horodytska O, Cabanes A, Fullana A. Non-intentionally added substances (NIAS) in recycled
plastics. Chemosphere. 2020;251:126373.
68.
Bradley E, Coulier L. An investigation into the reaction and breakdown products from starting
substances used to produce food contact plastics. Report. London: Central Science Laboratory; 2007
August 2007. Report No.: FD 07/01 Contract No.: FD07/01.
69.
Bauer A, Jesús F, Gómez Ramos MJ, Lozano A, Fernández-Alba AR. Identification of
unexpected chemical contaminants in baby food coming from plastic packaging migration by high
resolution accurate mass spectrometry. Food Chemistry. 2019;295:274-88.
70.
Geueke B. Non-intentionally added substances (NIAS). Food Packaging Forum Foundation;
2018 June 2018.
71.
COMMISSION REGULATION (EU) No 10/2011 of 14 January 2011 on plastic materials and
articles intended to come into contact with food, (2011).
72.
FDA. Guidance for Industry: Preparation of Premarket Submissions for Food Contact
Substances: Chemistry Recommendations. 2007 [Available from: https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/guidance-industry-preparation-premarket-submissions-foodcontact-substances-chemistry.
73.
Koster S, Bani-Estivals M, Bonuomo M, Bradley E, Chagnon M, Garcia M, et al. Guidance on
best practices on the risk assessment of non-intentionally added substances (NIAS) in food contact
materials and articles. ILSI Europe; 2015.
74.
Koster S, Rennen M, Leeman W, Houben G, Muilwijk B, van Acker F, et al. A novel safety
assessment strategy for non-intentionally added substances (NIAS) in carton food contact materials. Food
Additives & Contaminants: Part A. 2013;31(3):422-43.
29
75.
Pieke EN, Granby K, Trier X, Smedsgaard J. A framework to estimate concentrations of
potentially unknown substances by semi-quantification in liquid chromatography electrospray ionization
mass spectrometry. Analytica Chimica Acta. 2017;975:30-41.
76.
Taylor RB, Sapozhnikova Y. Assessing Chemical Migration from Plastic Food Packaging into
Food Simulant by Gas and Liquid Chromatography with High-Resolution Mass Spectrometry. Journal of
Agricultural and Food Chemistry. 2022;70(16):4805-16.
77.
Leeman W, Krul L. Non-intentionally added substances in food contact materials: how to ensure
consumer safety. Current Opinion in Food Science. 2015;6:33-7.
78.
Omer E, Bichon E, Hutinet S, Royer A-L, Monteau F, Germon H, et al. Toward the
characterisation of non-intentionally added substances migrating from polyester-polyurethane lacquers by
comprehensive gas chromatography-mass spectrometry technologies. Journal of Chromatography A.
2019;1601:327-34.
79.
Sapozhnikova Y, Nuñez A, Johnston J. Screening of chemicals migrating from plastic food
contact materials for oven and microwave applications by liquid and gas chromatography - Orbitrap mass
spectrometry. Journal of Chromatography A. 2021;1651:462261.
80.
Bschir K. Risk, Uncertainty and Precaution in Science: The case of the Threshold of
Toxicological Concern Approach in Food Toxicology. J Sci Eng Ethics. accepted.
81.
Van Bossuyt M, Van Hoeck E, Vanhaecke T, Rogiers V, Mertens B. Safeguarding human health
using in silico tools? Archives of Toxicology. 2017;91(7):2705-6.
82.
Bailey GS, Reddy AP, Pereira CB, Harttig U, Baird W, Spitsbergen JM, et al. Nonlinear Cancer
Response at Ultralow Dose: A 40800-Animal ED001 Tumor and Biomarker Study. Chemical Research in
Toxicology. 2009;22(7):1264-76.
83.
Williams DE, Orner G, Willard KD, Tilton S, Hendricks JD, Pereira C, et al. Rainbow Trout
(Oncorhynchus mykiss) and Ultra-Low Dose Cancer Studies. Comparative Biochemistry and Physiology.
2009;149:175-81.
84.
Neltner TG, Alger HM, Leonard JE, Maffini MV. Data gaps in toxicity testing of chemicals
allowed in food in the United States. Reproductive Toxicology. 2013;42:85-94.
85.
Madia F, Worth A, Whelan M, Corvi R. Carcinogenicity assessment: Addressing the challenges
of cancer and chemicals in the environment. Environment international. 2019;128:417-29.
86.
Scholz S, Brack W, Escher BI, Hackermüller J, Liess M, von Bergen M, et al. The EU chemicals
strategy for sustainability: an opportunity to develop new approaches for hazard and risk assessment.
Archives of Toxicology. 2022;96(8):2381-6.
87.
Bennett D, Bellinger DC, Birnbaum LS, Bradman A, Chen A, Cory-Slechta DA, et al. Project
TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement.
Environmental health perspectives. 2016;124(7):A118-A22.
88.
Mohanto NC, Ito Y, Kato S, Kamijima M. Life-Time Environmental Chemical Exposure and
Obesity: Review of Epidemiological Studies Using Human Biomonitoring Methods. Frontiers in
Endocrinology. 2021;12.
89.
Foresta C, Tescari S, Di Nisio A. Impact of perfluorochemicals on human health and
reproduction: a male's perspective. J Endocrinol Invest. 2018;41(6):639-45.
90.
Nerín C, Bourdoux S, Faust B, Gude T, Lesueur C, Simat T, et al. Guidance in selecting
analytical techniques for identification and quantification of non-intentionally added substances (NIAS)
in food contact materials (FCMS). Food Additives & Contaminants: Part A. 2022;39(3):620-43.
30
91.
EU. Chemicals Strategy for Sustainability. Towards a Toxic-Free Environment. European
Commission; 2020.
92.
Groh KJ, Muncke J. In Vitro Toxicity Testing of Food Contact Materials: State-of-the-Art and
Future Challenges. Comprehensive Reviews in Food Science and Food Safety. 2017;16(5):1123–50.
93.
Severin I, Souton E, Dahbi L, Chagnon MC. Use of bioassays to assess hazard of food contact
material extracts: State of the art. Food and Chemical Toxicology. 2017;105:429-47.
94.
Richard AM, Judson RS, Houck KA, Grulke CM, Volarath P, Thillainadarajah I, et al. ToxCast
Chemical Landscape: Paving the Road to 21st Century Toxicology. Chem Res Toxicol. 2016;29(8):122551.
95.
Tice RR, Austin CP, Kavlock RJ, Bucher JR. Improving the human hazard characterization of
chemicals: a Tox21 update. Environ Health Perspect. 2013;121(7):756-65.
96.
Filer DL, Hoffman K, Sargis RM, Trasande L, Kassotis CD. On the Utility of ToxCast-Based
Predictive Models to Evaluate Potential Metabolic Disruption by Environmental Chemicals. Environ
Health Perspect. 2022;130(5):57005.
97.
Janesick AS, Dimastrogiovanni G, Vanek L, Boulos C, Chamorro-García R, Tang W, et al. On
the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens. Environ Health Perspect.
2016;124(8):1214-26.
98.
Schug TT, Abagyan R, Blumberg B, Collins TJ, Crews D, DeFur PL, et al. Designing endocrine
disruption out of the next generation of chemicals. Green Chemistry. 2013.
99.
Fitz-James MH, Cavalli G. Molecular mechanisms of transgenerational epigenetic inheritance.
Nature Reviews Genetics. 2022;23(6):325-41.
100.
Street ME, Audouze K, Legler J, Sone H, Palanza P. Endocrine Disrupting Chemicals: Current
Understanding, New Testing Strategies and Future Research Needs. International Journal of Molecular
Sciences. 2021;22(2):933.
101.
Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I, et al. Key Characteristics of
Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis. Environ Health Perspect.
2016;124(6):713-21.
102.
Guyton KZ, Rusyn I, Chiu WA, Corpet DE, van den Berg M, Ross MK, et al. Application of the
key characteristics of carcinogens in cancer hazard identification. Carcinogenesis. 2018;39(4):614-22.
103.
Krewski D, Bird M, Al-Zoughool M, Birkett N, Billard M, Milton B, et al. Key characteristics of
86 agents known to cause cancer in humans. Journal of Toxicology and Environmental Health, Part B.
2019;22(7-8):244-63.
104.
Al-Zoughool M, Bird M, Rice J, Baan RA, Billard M, Birkett N, et al. Development of a
database on key characteristics of human carcinogens. Journal of Toxicology and Environmental Health,
Part B. 2019;22(7-8):264-87.
105.
Guyton KZ, Schubauer-Berigan MK. Invited Perspective: Prioritizing Chemical Testing and
Evaluation Using Validated in Vitro Assays Relevant to Key Characteristics. Environmental health
perspectives. 2021;129(7):071303.
106.
Rusyn I, Arzuaga X, Cattley RC, Corton JC, Ferguson SS, Godoy P, et al. Key Characteristics of
Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver
Toxicity. Hepatology. 2021;74(6):3486-96.
31
107.
La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB, et al.
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard
identification. Nature Reviews Endocrinology. 2020;16(1):45-57.
108.
Luderer U, Eskenazi B, Hauser R, Korach KS, McHale CM, Moran F, et al. Proposed Key
Characteristics of Female Reproductive Toxicants as an Approach for Organizing and Evaluating
Mechanistic Data in Hazard Assessment. Environmental health perspectives. 2019;127(7):075001.
109.
Arzuaga X, Smith MT, Gibbons CF, Skakkebaek NE, Yost EE, Beverly BEJ, et al. Proposed
Key Characteristics of Male Reproductive Toxicants as an Approach for Organizing and Evaluating
Mechanistic Evidence in Human Health Hazard Assessments. Environ Health Perspect.
2019;127(6):65001.
110.
Lind L, Araujo JA, Barchowsky A, Belcher S, Berridge BR, Chiamvimonvat N, et al. Key
Characteristics of Cardiovascular Toxicants. Environmental health perspectives. 2021;129(9):095001.
111.
Germolec DR, Lebrec H, Anderson SE, Burleson GR, Cardenas A, Corsini E, et al. Consensus
on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification. Environ Health
Perspect. 2022;130(10):105001.
112.
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, et al. Adverse
Outcome Pathways: A Conceptual Framework To Support Ecotoxicology Research And Risk
Assessment. . Environmental Toxicology and Chemistry. 2010;29(3):730-41.
113.
Coumoul X, Barouki R, Koual M, Audouze K, Tomkiewicz C. Activation of the AhR leading to
breast cancer. AOP 439 2022 [Available from: https://aopwiki.org/aops/439.
114.
Friedman KP, Crofton K, Gilbert M. Upregulation of Thyroid Hormone Catabolism via
Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in
Mammals. AOP 8 2022 [Available from: https://aopwiki.org/aops/8.
115.
Willis R. Pathology of tumors. London, England: Butterworth & Co Ltd; 1948.
116.
Naxerova K. Mutation fingerprints encode cellular histories. Nature. 2021;597:334-6.
117.
Sonnenschein C, Soto AM. Over a century of cancer research: Inconvenient truths and
promising leads. PLOS Biology. 2020;18(4):e3000670.
118.
Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in
rat mammary gland carcinogenesis. Journal of Cell Science. 2004;117(8):1495-502.
119.
L R-J, MJ B. Breast cancer by proxy: can the microenvironment be both the cause and
consequence? . Trends Mol Med. 2009;15(1):5-13.
120.
Keri RA, Ho S-M, Hunt PA, Knudsen KE, Soto AM, Prins GS. An Evaluation of Evidence for
the Carcinogenic Activity of Bisphenol A. Reprod Tox. 2007;24(2):240-52.
121.
IARC. Chemical Agents and Related Occupations. IARC Monographs on the Evaluation of
Carcinogenic Risks to Humans Volume 100F. Lyon, France: International Agency for Research on
Cancer; 2012.
122.
Kim HS, Lee YJ, Koo YJ, Pack EC, Lim KM, Choi DW. Migration of monomers, plastic
additives, and non-intentionally added substances from food utensils made of melamine–formaldehyde
resin following ultraviolet sterilization. Food Control. 2021;125:107981.
123.
Bach C, Dauchy X, Severin I, Munoz JF, Etienne S, Chagnon MC. Effect of temperature on the
release of intentionally and non-intentionally added substances from polyethylene terephthalate (PET)
bottles into water: chemical analysis and potential toxicity. Food Chem. 2013;139(1-4):672-80.
32
124.
NTP. RoC Review of Antimony Trioxide: U.S. Department of Health and Human Services;
2021 [Available from:
https://ntp.niehs.nih.gov/whatwestudy/assessments/cancer/completed/antimonyt/index.html.
125.
IARC. Agents classified by the IARC monographs, volumes 1–129.
https://monographs.iarc.who.int/agents-classified-by-the-iarc/; 2022.
126.
Westerhoff P, Prapaipong P, Shock E, Hillaireau A. Antimony leaching from polyethylene
terephthalate (PET) plastic used for bottled drinking water. Water Res. 2008;42(3):551-6.
127.
Trier X, Granby K, Christensen J. Polyfluorinated surfactants (PFS) in paper and board coatings
for food packaging. Environmental Science and Pollution Research. 2011:1-13.
128.
Minet L, Wang Z, Shalin A, Bruton TA, Blum A, Peaslee GF, et al. Use and release of per- and
polyfluoroalkyl substances (PFASs) in consumer food packaging in U.S. and Canada. Environmental
Science: Processes & Impacts. 2022;24(11):2032-42.
129.
Benbrahim-Tallaa L, Lauby-Secretan B, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, et al.
Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane,
and 1,3-propane sultone. The Lancet Oncology. 2014;15(9):924-5.
130.
Rider CV, McHale CM, Webster TF, Lowe L, Goodson WH, Merrill MAL, et al. Using the Key
Characteristics of Carcinogens to Develop Research on Chemical Mixtures and Cancer. Environmental
health perspectives. 2021;129(3):035003.
131.
OECD. Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines. 2015.
132.
OECD. OECD Test Guidelines for Chemicals 2022 [Available from:
https://www.oecd.org/chemicalsafety/testing/oecdguidelinesforthetestingofchemicals.htm.
133.
EFSA. Guidance document on the submission of a dossier on a substance to be used in Food
Contact Materials for evaluation by EFSA by the Panel on additives, flavourings, processing aids and
materials in contact with food (AFC). EFSA Journal. 2008.
134.
Pinter E, Rainer B, Czerny T, Riegel E, Schilter B, Marin-Kuan M, et al. Evaluation of the
Suitability of Mammalian In Vitro Assays to Assess the Genotoxic Potential of Food Contact Materials.
Foods. 2020;9(2).
135.
Chiara F, Indraccolo S, Trevisan A. Filling the gap between risk assessment and molecular
determinants of tumor onset. Carcinogenesis. 2020;42(4):507-16.
136.
Hwang SH, Yeom H, Han BI, Ham BJ, Lee YM, Han MR, et al. Predicting Carcinogenic
Mechanisms of Non-Genotoxic Carcinogens via Combined Analysis of Global DNA Methylation and In
Vitro Cell Transformation. Int J Mol Sci. 2020;21(15).
137.
Soto AM, Brisken C, Schaeberle CM, Sonnenschein C. Does cancer start in the womb? Altered
mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine
disruptors. J Mammary Gland Biol Neoplasia. 2013;18:199-208.
138.
WHO. Cardiovascular diseases (CVDs) 2021 [Available from: https://www.who.int/newsroom/fact-sheets/detail/cardiovascular-diseases-(cvds).
139.
Wen Z-J, Wang Z-Y, Zhang Y-F. Adverse cardiovascular effects and potential molecular
mechanisms of DEHP and its metabolites—A review. Science of The Total Environment.
2022;847:157443.
140.
El-Kersh K, Danielle Hopkins C, Wu X, Rai SN, Cai L, Huang J. Plasma level of antimony
correlates with pulmonary arterial hypertension severity. Current Research in Toxicology.
2022;3:100080.
33
141.
Yan S, Chen Y, Dong M, Song W, Belcher SM, Wang H-S. Bisphenol A and 17β-Estradiol
Promote Arrhythmia in the Female Heart via Alteration of Calcium Handling. PloS one.
2011;6(9):e25455.
142.
Gear R, Kendziorski JA, Belcher SM. Effects of bisphenol A on incidence and severity of
cardiac lesions in the NCTR-Sprague-Dawley rat: A CLARITY-BPA study. Toxicol Lett. 2017;275:12335.
143.
Gao X, Wang HS. Impact of bisphenol a on the cardiovascular system - epidemiological and
experimental evidence and molecular mechanisms. Int J Environ Res Public Health. 2014;11(8):8399413.
144.
Jokinen MP, Lieuallen WG, Boyle MC, Johnson CL, Malarkey DE, Nyska A. Morphologic
Aspects of Rodent Cardiotoxicity in a Retrospective Evaluation of National Toxicology Program Studies.
Toxicologic Pathology. 2011;39(5):850-60.
145.
FDA. Impact Story: Improved Assessment of Cardiotoxic Risk in Drug Candidates: The
Comprehensive in vitro Proarrhythmia Assay 2022 [Available from:
https://www.fda.gov/drugs/regulatory-science-action/impact-story-improved-assessment-cardiotoxic-riskdrug-candidates-comprehensive-vitro-proarrhythmia.
146.
CIPA. CIPA Initiative 2019 [Available from: https://cipaproject.org/.
147.
Kim JI, Lee YA, Shin CH, Hong Y-C, Kim B-N, Lim Y-H. Association of bisphenol A,
bisphenol F, and bisphenol S with ADHD symptoms in children. Environment international.
2022;161:107093.
148.
Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet.
2006;368(9553):2167-78.
149.
Maffini MV, Trasande L, Neltner TG. Perchlorate and Diet: Human Exposures, Risks, and
Mitigation Strategies. Curr Environ Health Rep. 2016;3(2):107-17.
150.
Arshajyothirmayi VA, Gulia KK. 26 - Neurotoxicity assays. In: Mohanan PV, editor.
Biomedical Product and Materials Evaluation: Woodhead Publishing; 2022. p. 703-23.
151.
Caffrey TM, Button EB, Robert J. Toward three-dimensional in vitro models to study
neurovascular unit functions in health and disease. Neural Regen Res. 2021;16(11):2132-40.
152.
Kilic O, Pamies D, Lavell E, Schiapparelli P, Feng Y, Hartung T, et al. Brain-on-a-chip model
enables analysis of human neuronal differentiation and chemotaxis. Lab Chip. 2016;16(21):4152-62.
153.
Maoz BM. Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms
for modeling the central nervous system. APL Bioengineering. 2021;5(3):030902.
154.
Park SE, Ahn J, Jeong H-E, Youn I, Huh D, Chung S. A three-dimensional in vitro model of the
peripheral nervous system. NPG Asia Materials. 2021;13(1):2.
155.
Cediel-Ulloa A, Lupu DL, Johansson Y, Hinojosa M, Özel F, Rüegg J. Impact of endocrine
disrupting chemicals on neurodevelopment: the need for better testing strategies for endocrine disruptioninduced developmental neurotoxicity. Expert Review of Endocrinology & Metabolism. 2022;17(2):13141.
156.
Kortenkamp A, Axelstad M, Baig AH, Bergman Å, Bornehag C-G, Cenijn P, et al. Removing
Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid
Hormone System-Disrupting Chemicals—The ATHENA Project. International Journal of Molecular
Sciences. 2020;21(9):3123.
34
157.
Sachana M, Willett C, Pistollato F, Bal-Price A. The potential of mechanistic information
organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity
(DNT) in vitro battery of assays. Reprod Toxicol. 2021;103:159-70.
158.
Blum J, Masjosthusmann S, Bartmann K, Bendt F, Dolde X, Dönmez A, et al. Establishment of
a human cell-based in vitro battery to assess developmental neurotoxicity hazard of chemicals.
Chemosphere. 2022;311(Pt 2):137035.
159.
Ruszkiewicz JA, Pinkas A, Miah MR, Weitz RL, Lawes MJA, Akinyemi AJ, et al. C. elegans as
a model in developmental neurotoxicology. Toxicology and Applied Pharmacology. 2018;354:126-35.
160.
Hunt PR, Olejnik N, Bailey KD, Vaught CA, Sprando RL. C. elegans Development and Activity
Test detects mammalian developmental neurotoxins. Food and Chemical Toxicology. 2018;121:583-92.
161.
Parng C, Roy NM, Ton C, Lin Y, McGrath P. Neurotoxicity assessment using zebrafish. Journal
of Pharmacological and Toxicological Methods. 2007;55(1):103-12.
162.
Rericha Y, Truong L, Leong C, Cao D, Field JA, Tanguay RL. Dietary Perfluorohexanoic Acid
(PFHxA) Exposures in Juvenile Zebrafish Produce Subtle Behavioral Effects across Generations. Toxics.
2022;10(7):372.
163.
Fitzgerald JA, Könemann S, Krümpelmann L, Županič A, vom Berg C. Approaches to Test the
Neurotoxicity of Environmental Contaminants in the Zebrafish Model: From Behavior to Molecular
Mechanisms. Environmental Toxicology and Chemistry. 2021;40(4):989-1006.
164.
Huff J, Jacobson MF, Davis DL. The Limits of Two-Year Bioassay Exposure Regimens for
Identifying Chemical Carcinogens. Environ Health Perspect. 2008;116(11):1439-42.
165.
Mohajer N, Du CY, Checkcinco C, Blumberg B. Obesogens: How They Are Identified and
Molecular Mechanisms Underlying Their Action. Front Endocrinol (Lausanne). 2021;12:780888.
166.
Heindel JJ, Howard S, Agay-Shay K, Arrebola JP, Audouze K, Babin PJ, et al. Obesity II:
Establishing causal links between chemical exposures and obesity. Biochem Pharmacol.
2022;199:115015.
167.
Heindel JJ. History of the Obesogen Field: Looking Back to Look Forward. Front Endocrinol
(Lausanne). 2019;10:14.
168.
Kassotis CD, Vom Saal FS, Babin PJ, Lagadic-Gossmann D, Le Mentec H, Blumberg B, et al.
Obesity III: Obesogen assays: Limitations, strengths, and new directions. Biochem Pharmacol.
2022;199:115014.
169.
Kassotis CD, Stapleton HM. Endocrine-Mediated Mechanisms of Metabolic Disruption and
New Approaches to Examine the Public Health Threat. Front Endocrinol (Lausanne). 2019;10:39.
170.
Seo Y, Shin TH, Kim HS. Current Strategies to Enhance Adipose Stem Cell Function: An
Update. Int J Mol Sci. 2019;20(15).
171.
Desai M, Ferrini MG, Jellyman JK, Han G, Ross MG. In vivo and in vitro bisphenol A exposure
effects on adiposity. J Dev Orig Health Dis. 2018;9(6):678-87.
172.
Shoucri BM, Hung VT, Chamorro-García R, Shioda T, Blumberg B. Retinoid X Receptor
Activation During Adipogenesis of Female Mesenchymal Stem Cells Programs a Dysfunctional
Adipocyte. Endocrinology. 2018;159(8):2863-83.
173.
Chamorro-Garcia R, Blumberg B. Current Research Approaches and Challenges in the
Obesogen Field. Front Endocrinol (Lausanne). 2019;10:167.
35
174.
Lane JM, Doyle JR, Fortin JP, Kopin AS, Ordovás JM. Development of an OP9 derived cell line
as a robust model to rapidly study adipocyte differentiation. PloS one. 2014;9(11):e112123.
175.
Tang QQ, Otto TC, Lane MD. Commitment of C3H10T1/2 pluripotent stem cells to the
adipocyte lineage. Proc Natl Acad Sci U S A. 2004;101(26):9607-11.
176.
Pillai HK, Fang M, Beglov D, Kozakov D, Vajda S, Stapleton HM, et al. Ligand Binding and
Activation of PPARγ by Firemaster® 550: Effects on Adipogenesis and Osteogenesis <i>in Vitro</i>.
Environmental health perspectives. 2014;122(11):1225-32.
177.
Völker J, Ashcroft F, Vedøy Å, Zimmermann L, Wagner M. Adipogenic Activity of Chemicals
Used in Plastic Consumer Products. Environmental Science & Technology. 2022;56(4):2487-96.
178.
Turner PA, Gurumurthy B, Bailey JL, Elks CM, Janorkar AV. Adipogenic Differentiation of
Human Adipose-Derived Stem Cells Grown as Spheroids. Process Biochem. 2017;59:312-20.
179.
Auerbach S, Filer D, Reif D, Walker V, Holloway AC, Schlezinger J, et al. Prioritizing
Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using
ToxCast™ High-Throughput Data. Environ Health Perspect. 2016;124(8):1141-54.
180.
Ye W, Ramos EH, Wong BC, Belsham DD. Beneficial Effects of Metformin and/or Salicylate
on Palmitate- or TNFα-Induced Neuroinflammatory Marker and Neuropeptide Gene Regulation in
Immortalized NPY/AgRP Neurons. PloS one. 2016;11(11):e0166973.
181.
Loganathan N, Salehi A, Chalmers JA, Belsham DD. Bisphenol A Alters Bmal1, Per2, and RevErba mRNA and Requires Bmal1 to Increase Neuropeptide Y Expression in Hypothalamic Neurons.
Endocrinology. 2018;160(1):181-92.
182.
Audouze K, Sarigiannis D, Alonso-Magdalena P, Brochot C, Casas M, Vrijheid M, et al.
Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic
Disorders—An Introduction to the OBERON Project. International Journal of Molecular Sciences.
2020;21(8):2988.
183.
Legler J, Zalko D, Jourdan F, Jacobs M, Fromenty B, Balaguer P, et al. The GOLIATH Project:
Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds.
International Journal of Molecular Sciences. 2020;21(10):3480.
184.
Küblbeck J, Vuorio T, Niskanen J, Fortino V, Braeuning A, Abass K, et al. The EDCMET
Project: Metabolic Effects of Endocrine Disruptors. International Journal of Molecular Sciences.
2020;21(8):3021.
185.
Dos Santos RS, Medina-Gali RM, Babiloni-Chust I, Marroqui L, Nadal A. In Vitro Assays to
Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic βCell Model. International Journal of Molecular Sciences. 2022;23(9):5040.
186.
Tolosa L, Jiménez N, Pérez G, Castell JV, Gómez-Lechón MJ, Donato MT. Customised in vitro
model to detect human metabolism-dependent idiosyncratic drug-induced liver injury. Archives of
Toxicology. 2018;92(1):383-99.
187.
Kim YE, Jeon HJ, Kim D, Lee SY, Kim KY, Hong J, et al. Quantitative Proteomic Analysis of
2D and 3D Cultured Colorectal Cancer Cells: Profiling of Tankyrase Inhibitor XAV939-Induced
Proteome. Scientific Reports. 2018;8(1):13255.
188.
Zeilinger K, Freyer N, Damm G, Seehofer D, Knöspel F. Cell sources for in vitro human liver
cell culture models. Exp Biol Med (Maywood). 2016;241(15):1684-98.
189.
Nicholson LB. The immune system. Essays Biochem. 2016;60(3):275-301.
36
190.
Germolec D, Luebke R, Rooney A, Shipkowski K, Vandebriel R, van Loveren H.
Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment.
Curr Opin Toxicol. 2017;5:55-9.
191.
Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Timmermann A, et al. Estimated
exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at
age 5-years. Journal of Immunotoxicology. 2017;14(1):188-95.
192.
Xie M-Y, Ni H, Zhao D-S, Wen L-Y, Li K-S, Yang H-H, et al. Exposure to bisphenol A and the
development of asthma: A systematic review of cohort studies. Reproductive Toxicology. 2016;65:224-9.
193.
Wang IJ, Chen C-Y, Bornehag C-G. Bisphenol A exposure may increase the risk of
development of atopic disorders in children. International Journal of Hygiene and Environmental Health.
2016;219(3):311-6.
194.
Kim EH, Jeon BH, Kim J, Kim YM, Han Y, Ahn K, et al. Exposure to phthalates and bisphenol
A are associated with atopic dermatitis symptoms in children: a time-series analysis. Environ Health.
2017;16(1):24.
195.
Gascon M, Casas M, Morales E, Valvi D, Ballesteros-Gómez A, Luque N, et al. Prenatal
exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. Journal of
Allergy and Clinical Immunology. 2015;135(2):370-8.e7.
196.
Corsini E, Roggen EL. Overview of in vitro assessment of immunotoxicity. Current Opinion in
Toxicology. 2017;5:13-8.
197.
Luebke R. Immunotoxicant screening and prioritization in the twenty-first century. Toxicol
Pathol. 2012;40(2):294-9.
198.
Deprouw C, Courties A, Fini JB, Clerget-Froidevaux MS, Demeneix B, Berenbaum F, et al.
Pollutants: a candidate as a new risk factor for osteoarthritis-results from a systematic literature review.
RMD Open. 2022;8(2).
199.
Naidenko OV, Andrews DQ, Temkin AM, Stoiber T, Uche UI, Evans S, et al. Investigating
Molecular Mechanisms of Immunotoxicity and the Utility of ToxCast for Immunotoxicity Screening of
Chemicals Added to Food. International Journal of Environmental Research and Public Health.
2021;18(7):3332.
200.
Ogungbesan A, Neal-Kluever A, Rice P. Exploring the use of current immunological assays for
the developmental immunotoxicity assessment of food contact materials. Food and Chemical Toxicology.
2019;133:110801.
201.
Levine H, Jørgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Mindlis I, et al.
Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update.
2017;23(6):646-59.
202.
Skakkebæk NE, Lindahl-Jacobsen R, Levine H, Andersson A-M, Jørgensen N, Main KM, et al.
Environmental factors in declining human fertility. Nature Reviews Endocrinology. 2022;18(3):139-57.
203.
Znaor A, Skakkebaek NE, Rajpert-De Meyts E, Kuliš T, Laversanne M, Gurney J, et al. Global
patterns in testicular cancer incidence and mortality in 2020. International Journal of Cancer.
2022;151(5):692-8.
204.
Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A metaanalysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update.
2006;12(6):673-83.
37
205.
Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an
increasingly common developmental disorder with environmental aspects: Opinion. Human
Reproduction. 2001;16(5):972-8.
206.
Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, Toppari J, Andersson AM, Eisenberg
ML, et al. Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic
Susceptibility. Physiol Rev. 2016;96(1):55-97.
207.
Jorgensen A, Svingen T, Miles H, Chetty T, Stukenborg JB, Mitchell RT. Environmental
Impacts on Male Reproductive Development: Lessons from Experimental Models. Hormone Research in
Paediatrics. 2021.
208.
Kortenkamp A. Which chemicals should be grouped together for mixture risk assessments of
male reproductive disorders? Mol Cell Endocrinol. 2020;499:110581.
209.
Soave I, Occhiali T, Assorgi C, Marci R, Caserta D. Environmental toxin exposure in polycystic
ovary syndrome women and possible ovarian neoplastic repercussion. Curr Med Res Opin.
2020;36(4):693-703.
210.
Nerín C, Su QZ, Vera P, Mendoza N, Ausejo R. Influence of nonylphenol from multilayer
plastic films on artificial insemination of sows. Anal Bioanal Chem. 2020;412(24):6519-28.
211.
Garcia-Calvo E, Machuca A, Nerín C, Rosales-Conrado N, Anunciação DS, Luque-Garcia JL.
Integration of untargeted and targeted mass spectrometry-based metabolomics provides novel insights
into the potential toxicity associated to surfynol. Food Chem Toxicol. 2020;146:111849.
212.
Boisvert A, Jones S, Issop L, Erythropel HC, Papadopoulos V, Culty M. In vitro functional
screening as a means to identify new plasticizers devoid of reproductive toxicity. Environmental
Research. 2016;150:496-512.
213.
Vessa B, Perlman B, McGovern PG, Morelli SS. Endocrine disruptors and female fertility: a
review of pesticide and plasticizer effects. F S Rep. 2022;3(2):86-90.
214.
Corton JC, Liu J, Kleinstreuer N, Gwinn MR, Ryan N. Towards replacement of animal tests with
in vitro assays: a gene expression biomarker predicts in vitro and in vivo estrogen receptor activity. Chem
Biol Interact. 2022;363:109995.
215.
Pinto CL, Markey K, Dix D, Browne P. Identification of candidate reference chemicals for in
vitro steroidogenesis assays. Toxicol In Vitro. 2018;47:103-19.
216.
Key Characteristics. Key Characteristics. Identifying the Key Characteristics of Hazardous
Chemicals and Other Exposures: A Collaborative Approach 2022 [Available from:
https://keycharacteristics.org/.
217.
Rajkumar A, Luu T, Beal MA, Barton-Maclaren TS, Hales BF, Robaire B. Phthalates and
alternative plasticizers differentially affect phenotypic parameters in gonadal somatic and germ cell
lines†. Biology of Reproduction. 2022;106(3):613-27.
218.
Marvel SW, To K, Grimm FA, Wright FA, Rusyn I, Reif DM. ToxPi Graphical User Interface
2.0: Dynamic exploration, visualization, and sharing of integrated data models. BMC Bioinformatics.
2018;19(1):80.
219.
Lizarraga LE, Suter GW, Lambert JC, Patlewicz G, Zhao JQ, Dean JL, et al. Advancing the
science of a read-across framework for evaluation of data-poor chemicals incorporating systematic and
new approach methods. Regul Toxicol Pharmacol. 2023;137:105293.
220.
Agency EC. Read-Across Assessment Framework (RAAF). European Chemicals Agency; 2017.
38
221.
Escher BI, Aїt-Aїssa S, Behnisch PA, Brack W, Brion F, Brouwer A, et al. Effect-based trigger
values for in vitro and in vivo bioassays performed on surface water extracts supporting the
environmental quality standards (EQS) of the European Water Framework Directive. Science of The
Total Environment. 2018;628-629:748-65.
222.
Neale PA, Escher BI, de Baat ML, Enault J, Leusch FDL. Effect-Based Trigger Values Are
Essential for the Uptake of Effect-Based Methods in Water Safety Planning. Environ Toxicol Chem.
2023;42(3):714-26.
223.
Escher BI, Neale PA. Effect-Based Trigger Values for Mixtures of Chemicals in Surface Water
Detected with In Vitro Bioassays. Environ Toxicol Chem. 2021;40(2):487-99.
224.
Robitaille J, Denslow ND, Escher BI, Kurita-Oyamada HG, Marlatt V, Martyniuk CJ, et al.
Towards regulation of Endocrine Disrupting chemicals (EDCs) in water resources using bioassays - A
guide to developing a testing strategy. Environ Res. 2022;205:112483.
225.
Escher BI, Neale PA, Leusch FD. Effect-based trigger values for in vitro bioassays: Reading
across from existing water quality guideline values. Water Res. 2015;81:137-48.
226.
EU. A Farm to Fork Strategy for a fair, healthy and environmentally-friendly food system.
European Commission; 2020.
227.
European Parliament. Implementation of the Food Contact Materials Regulation. European
Parliament resolution of 6 October 2016 on the implementation of the Food Contact Materials Regulation
(EC) No 1935/2004 (2015/2259(INI)). 2016. Contract No.: P8_TA(2016)0384.
228.
Fenner K, Scheringer M. The Need for Chemical Simplification As a Logical Consequence of
Ever-Increasing Chemical Pollution. Environ Sci Technol. 2021;55(21):14470-2.
229.
IARC. Some Chemicals Used as Solvents and in Polymer Manufacture. IARC Monographs on
the Evaluation of Carcinogenic Risks to Humans Volume 110. Lyon, France; 2016.
230.
ATSDR. Toxicological Profile for Perfluoroalkyls 2021 [Available from:
https://wwwn.cdc.gov/TSP/ToxProfiles/ToxProfiles.aspx?id=1117&tid=237.
231.
Melnick RL. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of
di(2-ethylhexyl)phthalate (DEHP)? Environ Health Perspect. 2001;109(5):437-42.
232.
Wan MLY, Co VA, El-Nezami H. Endocrine disrupting chemicals and breast cancer: a
systematic review of epidemiological studies. Crit Rev Food Sci Nutr. 2022;62(24):6549-76.
233.
Moon S, Yu SH, Lee CB, Park YJ, Yoo HJ, Kim DS. Effects of bisphenol A on cardiovascular
disease: An epidemiological study using National Health and Nutrition Examination Survey 2003–2016
and meta-analysis. Science of The Total Environment. 2021;763:142941.
234.
Zhang Y-F, Shan C, Wang Y, Qian L-L, Jia D-D, Zhang Y-F, et al. Cardiovascular toxicity and
mechanism of bisphenol A and emerging risk of bisphenol S. Science of The Total Environment.
2020;723:137952.
235.
Wehbe Z, Nasser SA, El-Yazbi A, Nasreddine S, Eid AH. Estrogen and Bisphenol A in
Hypertension. Current Hypertension Reports. 2020;22(3):23.
236.
Ramadan M, Cooper B, Posnack NG. Bisphenols and phthalates: Plastic chemical exposures can
contribute to adverse cardiovascular health outcomes. Birth Defects Research. 2020;112(17):1362-85.
237.
Fu X, Xu J, Zhang R, Yu J. The association between environmental endocrine disruptors and
cardiovascular diseases: A systematic review and meta-analysis. Environmental Research.
2020;187:109464.
39
238.
Rebolledo-Solleiro D, Flores LYC, Solleiro-Villavicencio H. Impact of BPA on behavior,
neurodevelopment and neurodegeneration. FBL. 2021;26(2):363-400.
239.
Radke EG, Braun JM, Nachman RM, Cooper GS. Phthalate exposure and neurodevelopment: A
systematic review and meta-analysis of human epidemiological evidence. Environment international.
2020;137:105408.
240.
Piekarski DJ, Diaz KR, McNerney MW. Perfluoroalkyl chemicals in neurological health and
disease: Human concerns and animal models. NeuroToxicology. 2020;77:155-68.
241.
Eales J, Bethel A, Galloway T, Hopkinson P, Morrissey K, Short RE, et al. Human health
impacts of exposure to phthalate plasticizers: An overview of reviews. Environment international.
2022;158:106903.
242.
Moore S, Paalanen L, Melymuk L, Katsonouri A, Kolossa-Gehring M, Tolonen H. The
Association between ADHD and Environmental Chemicals—A Scoping Review. International
Journal of Environmental Research and Public Health. 2022;19(5):2849.
243.
Li N, Papandonatos GD, Calafat AM, Yolton K, Lanphear BP, Chen A, et al. Gestational and
childhood exposure to phthalates and child behavior. Environ Int. 2020;144:106036.
244.
Park S, Lee JM, Kim JW, Cheong JH, Yun HJ, Hong YC, et al. Association between phthalates
and externalizing behaviors and cortical thickness in children with attention deficit hyperactivity disorder.
Psychol Med. 2015;45(8):1601-12.
245.
van den Dries MA, Guxens M, Spaan S, Ferguson KK, Philips E, Santos S, et al. Phthalate and
Bisphenol Exposure during Pregnancy and Offspring Nonverbal IQ. Environ Health Perspect.
2020;128(7):77009.
246.
Predieri B, Bruzzi P, Bigi E, Ciancia S, Madeo SF, Lucaccioni L, et al. Endocrine Disrupting
Chemicals and Type 1 Diabetes. International Journal of Molecular Sciences. 2020;21(8):2937.
247.
Wang B, Li M, Zhao Z, Lu J, Chen Y, Xu Y, et al. Urinary bisphenol A concentration and
glucose homeostasis in non-diabetic adults: a repeated-measures, longitudinal study. Diabetologia.
2019;62(9):1591-600.
248.
Rancière F, Lyons JG, Loh VHY, Botton J, Galloway T, Wang T, et al. Bisphenol A and the risk
of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence.
Environmental Health. 2015;14(1):1-23.
249.
Akash MSH, Sabir S, Rehman K. Bisphenol A-induced metabolic disorders: From exposure to
mechanism of action. Environmental Toxicology and Pharmacology. 2020;77:103373.
250.
He X, Liu Y, Xu B, Gu L, Tang W. PFOA is associated with diabetes and metabolic alteration in
US men: National Health and Nutrition Examination Survey 2003-2012. Sci Total Environ.
2018;625:566-74.
251.
Radke EG, Braun JM, Meeker JD, Cooper GS. Phthalate exposure and male reproductive
outcomes: A systematic review of the human epidemiological evidence. Environment international.
2018;121:764-93.
252.
Dales RE, Kauri LM, Cakmak S. The associations between phthalate exposure and insulin
resistance, β-cell function and blood glucose control in a population-based sample. Science of The Total
Environment. 2018;612:1287-92.
253.
Pérez-Bermejo M, Mas-Pérez I, Murillo-Llorente MT. The Role of the Bisphenol A in Diabetes
and Obesity. Biomedicines. 2021;9(6).
40
254.
Wu W, Li M, Liu A, Wu C, Li D, Deng Q, et al. Bisphenol A and the Risk of Obesity a
Systematic Review With Meta-Analysis of the Epidemiological Evidence. Dose Response.
2020;18(2):1559325820916949.
255.
Liu P, Yang F, Wang Y, Yuan Z. Perfluorooctanoic Acid (PFOA) Exposure in Early Life
Increases Risk of Childhood Adiposity: A Meta-Analysis of Prospective Cohort Studies. Int J Environ
Res Public Health. 2018;15(10).
256.
Geiger SD, Yao P, Vaughn MG, Qian Z. PFAS exposure and overweight/obesity among
children in a nationally representative sample. Chemosphere. 2021;268:128852.
257.
Ribeiro CM, Beserra BTS, Silva NG, Lima CL, Rocha PRS, Coelho MS, et al. Exposure to
endocrine-disrupting chemicals and anthropometric measures of obesity: a systematic review and metaanalysis. BMJ Open. 2020;10(6):e033509.
258.
Buckley JP, Engel SM, Braun JM, Whyatt RM, Daniels JL, Mendez MA, et al. Prenatal
Phthalate Exposures and Body Mass Index Among 4- to 7-Year-old Children: A Pooled Analysis.
Epidemiology. 2016;27(3):449-58.
259.
Zhang Q, Li X, Liu X, Dong M, Xiao J, Wang J, et al. Association between maternal antimony
exposure and risk of gestational diabetes mellitus: A birth cohort study. Chemosphere. 2020;246:125732.
260.
Shaffer RM, Ferguson KK, Sheppard L, James-Todd T, Butts S, Chandrasekaran S, et al.
Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during
pregnancy. Environ Int. 2019;123:588-96.
261.
Midya V, Colicino E, Conti DV, Berhane K, Garcia E, Stratakis N, et al. Association of Prenatal
Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children. JAMA Network Open.
2022;5(7):e2220176-e.
262.
Stratakis N, D VC, Jin R, Margetaki K, Valvi D, Siskos AP, et al. Prenatal Exposure to
Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children.
Hepatology. 2020;72(5):1758-70.
263.
DeWitt JC, Blossom SJ, Schaider LA. Exposure to per-fluoroalkyl and polyfluoroalkyl
substances leads to immunotoxicity: epidemiological and toxicological evidence. Journal of exposure
science & environmental epidemiology. 2019;29(2):148-56.
264.
Hsieh TJ, Hsieh PC, Tsai YH, Wu CF, Liu CC, Lin MY, et al. Melamine induces human renal
proximal tubular cell injury via transforming growth factor-β and oxidative stress. Toxicol Sci.
2012;130(1):17-32.
265.
Sharma A, Mollier J, Brocklesby RWK, Caves C, Jayasena CN, Minhas S. Endocrine-disrupting
chemicals and male reproductive health. Reproductive Medicine and Biology. 2020;19(3):243-53.
266.
Estill M, Hauser R, Nassan FL, Moss A, Krawetz SA. The effects of di-butyl phthalate exposure
from medications on human sperm RNA among men. Scientific Reports. 2019;9(1):12397.
267.
Thurston SW, Mendiola J, Bellamy AR, Levine H, Wang C, Sparks A, et al. Phthalate exposure
and semen quality in fertile US men. Andrology. 2016;4(4):632-8.
268.
Messerlian C, Souter I, Gaskins AJ, Williams PL, Ford JB, Chiu YH, et al. Urinary phthalate
metabolites and ovarian reserve among women seeking infertility care. Hum Reprod. 2016;31(1):75-83.
269.
IARC. Some Chemicals That Cause Tumours of the Urinary Tract in Rodents. IARC
Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 119. Lyon, France; 2019.
270.
IARC. Some Aromatic Amines, Organic Dyes, and Related Exposures. IARC Monographs on
the Evaluation of Carcinogenic Risks to Humans Volume 99. Lyon, France: IARC; 2010.
41
271.
NTP. Report on Carcinogens. Monograph on Antimony Trioxide. U.S. Department of Health
and Human Services; 2018 October 2018.
272.
Temkin AM, Hocevar BA, Andrews DQ, Naidenko OV, Kamendulis LM. Application of the
Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances. International Journal of
Environmental Research and Public Health. 2020;17(5):1668.
273.
Pierozan P, Jerneren F, Karlsson O. Perfluorooctanoic acid (PFOA) exposure promotes
proliferation, migration and invasion potential in human breast epithelial cells. Arch Toxicol.
2018;92(5):1729-39.
274.
Charazac A, Hinault C, Dolfi B, Hautier S, Decondé Le Butor C, Bost F, et al. Low Doses of
PFOA Promote Prostate and Breast Cancer Cells Growth through Different Pathways. Int J Mol Sci.
2022;23(14).
275.
Hager E, Chen J, Zhao L. Minireview: Parabens Exposure and Breast Cancer. Int J Environ Res
Public Health. 2022;19(3).
276.
IARC. Some Chemicals Present in Industrial and Consumer Products, Food and Drinking-water.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 101. Lyon, France:
IARC; 2012.
277.
Sang C, Song Y, Jin TW, Zhang S, Fu L, Zhao Y, et al. Bisphenol A induces ovarian cancer cell
proliferation and metastasis through estrogen receptor-α pathways. Environ Sci Pollut Res Int.
2021;28(27):36060-8.
278.
Jun JH, Oh JE, Shim JK, Kwak YL, Cho JS. Effects of bisphenol A on the proliferation,
migration, and tumor growth of colon cancer cells: In vitro and in vivo evaluation with mechanistic
insights related to ERK and 5-HT3. Food Chem Toxicol. 2021;158:112662.
279.
Dhimolea E, Wadia PR, Murray TJ, Settles ML, Treitman JD, Sonnenschein C, et al. Prenatal
exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to
neoplastic development. PloS one. 2014;9(7):e99800.
280.
Prins GS, Hu WY, Shi GB, Hu DP, Majumdar S, Li G, et al. Bisphenol A promotes human
prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate
epithelium. Endocrinology. 2014;155(3):805-17.
281.
Pant J, Ranjan P, Deshpande SB. Bisphenol A decreases atrial contractility involving NOdependent G-cyclase signaling pathway. J Appl Toxicol. 2011;31(7):698-702.
282.
Kofron CM, Kim TY, Munarin F, Soepriatna AH, Kant RJ, Mende U, et al. A predictive in vitro
risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues. Scientific
Reports. 2021;11(1):10228.
283.
Hyun SA, Lee CY, Ko MY, Chon SH, Kim YJ, Seo JW, et al. Cardiac toxicity from bisphenol A
exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol.
2021;428:115696.
284.
Krishna S, Berridge B, Kleinstreuer N. High-Throughput Screening to Identify Chemical
Cardiotoxic Potential. Chem Res Toxicol. 2021;34(2):566-83.
285.
Cooper BL, Posnack NG. Characteristics of Bisphenol Cardiotoxicity: Impaired Excitability,
Contractility, and Relaxation. Cardiovasc Toxicol. 2022;22(3):273-80.
286.
Jokinen MP, Lieuallen WG, Johnson CL, Dunnick J, Nyska A. Characterization of spontaneous
and chemically induced cardiac lesions in rodent model systems: the national toxicology program
experience. Cardiovasc Toxicol. 2005;5(2):227-44.
42
287.
Mariana M, Feiteiro J, Verde I, Cairrao E. The effects of phthalates in the cardiovascular and
reproductive systems: A review. Environment international. 2016;94:758-76.
288.
12.
Kirk AB. Environmental perchlorate: Why it matters. Analytica Chimica Acta. 2006;567(1):4-
289.
Hlisníková H, Petrovičová I, Kolena B, Šidlovská M, Sirotkin A. Effects and mechanisms of
phthalates' action on neurological processes and neural health: a literature review. Pharmacol Rep.
2021;73(2):386-404.
290.
McDonough CM, Xu HS, Guo TL. Toxicity of bisphenol analogues on the reproductive,
nervous, and immune systems, and their relationships to gut microbiome and metabolism: insights from a
multi-species comparison. Critical Reviews in Toxicology. 2021;51(4):283-300.
291.
Wang Z, Alderman MH, Asgari C, Taylor HS. Fetal Bisphenol-A Induced Changes in Murine
Behavior and Brain Gene Expression Persisted in Adult-aged Offspring. Endocrinology. 2020;161(12).
292.
Naderi M, Kwong RWM. A comprehensive review of the neurobehavioral effects of bisphenol S
and the mechanisms of action: New insights from in vitro and in vivo models. Environment international.
2020;145:106078.
293.
Villar-Pazos S, Martinez-Pinna J, Castellano-Muñoz M, Alonso-Magdalena P, Marroqui L,
Quesada I, et al. Molecular mechanisms involved in the non-monotonic effect of bisphenol-a on ca2+
entry in mouse pancreatic β-cells. Sci Rep. 2017;7(1):11770.
294.
Martinez-Pinna J, Marroqui L, Hmadcha A, Lopez-Beas J, Soriano S, Villar-Pazos S, et al.
Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic
beta cells. Diabetologia. 2019;62(9):1667-80.
295.
Wassenaar PNH, Trasande L, Legler J. Systematic Review and Meta-Analysis of Early-Life
Exposure to Bisphenol A and Obesity-Related Outcomes in Rodents. Environ Health Perspect.
2017;125(10):106001.
296.
Desai M, Ferrini MG, Han G, Jellyman JK, Ross MG. In vivo maternal and in vitro BPA
exposure effects on hypothalamic neurogenesis and appetite regulators. Environ Res. 2018;164:45-52.
297.
Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK. Plastics derived endocrine
disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity,
reproductive disease and sperm epimutations. PloS one. 2013;8(1):e55387.
298.
Wang D, Zhao H, Fei X, Synder SA, Fang M, Liu M. A comprehensive review on the analytical
method, occurrence, transformation and toxicity of a reactive pollutant: BADGE. Environment
international. 2021;155:106701.
299.
Rotenberg Iu S, Mazaev VT, Shlepnina TG. Peculiarities of alkyl tin effects on respiration and
oxidative phosphorylation of rat liver mitochondria. Ukr Biokhim Zh (1978). 1978;50(6):695-700.
300.
Larsson-Nyrén G, Sehlin J, Rorsman P, Renström E. Perchlorate stimulates insulin secretion by
shifting the gating of L-type Ca2+ currents in mouse pancreatic B-cells towards negative potentials.
Pflugers Arch. 2001;441(5):587-95.
301.
Qin W-P, Cao L-Y, Li C-H, Guo L-H, Colbourne J, Ren X-M. Perfluoroalkyl Substances
Stimulate Insulin Secretion by Islet β Cells via G Protein-Coupled Receptor 40. Environmental Science &
Technology. 2020;54(6):3428-36.
302.
Sant KE, Jacobs HM, Borofski KA, Moss JB, Timme-Laragy AR. Embryonic exposures to
perfluorooctanesulfonic acid (PFOS) disrupt pancreatic organogenesis in the zebrafish, Danio rerio.
Environ Pollut. 2017;220(Pt B):807-17.
43
303.
Marroqui L, Martinez-Pinna J, Castellano-Muñoz M, Dos Santos RS, Medina-Gali RM, Soriano
S, et al. Bisphenol-S and Bisphenol-F alter mouse pancreatic β-cell ion channel expression and activity
and insulin release through an estrogen receptor ERβ mediated pathway. Chemosphere.
2021;265:129051.
304.
Garcia-Calvo E, Machuca A, Nerín C, Rosales-Conrado N, Anunciação DS, Luque-Garcia JL.
Integration of untargeted and targeted mass spectrometry-based metabolomics provides novel insights
into the potential toxicity associated to surfynol. Food and Chemical Toxicology. 2020;146:111849.
305.
Nerin C, Canellas E, Vera P, Garcia-Calvo E, Luque-Garcia JL, Cámara C, et al. A common
surfactant used in food packaging found to be toxic for reproduction in mammals. Food and Chemical
Toxicology. 2018;113:115-24.
306.
Nerin C, Ubeda JL, Alfaro P, Dahmani Y, Aznar M, Canellas E, et al. Compounds from
multilayer plastic bags cause reproductive failures in artificial insemination. Sci Rep. 2014;4.
307.
Li J, Zheng L, Wang X, Yao K, Shi L, Sun X, et al. Taurine protects INS-1 cells from apoptosis
induced by Di(2-ethylhexyl) phthalate via reducing oxidative stress and autophagy. Toxicol Mech
Methods. 2019;29(6):445-56.
308.
Nowak K, Jabłońska E, Ratajczak-Wrona W. Immunomodulatory effects of synthetic endocrine
disrupting chemicals on the development and functions of human immune cells. Environment
international. 2019;125:350-64.
309.
Liu W, Zhang J, Liang X, Wang Y, Liu R, Zhang R, et al. Environmental concentrations of 2, 4DTBP cause immunotoxicity in zebrafish (Danio rerio) and may elicit ecological risk to wildlife.
Chemosphere. 2022;308:136465.
310.
Hessel EVS, Tonk ECM, Bos PMJ, van Loveren H, Piersma AH. Developmental
immunotoxicity of chemicals in rodents and its possible regulatory impact. Critical Reviews in
Toxicology. 2015;45(1):68-82.
311.
Liu Q. Effects of Environmental Endocrine-Disrupting Chemicals on Female Reproductive
Health. In: Zhang H, Yan J, editors. Environment and Female Reproductive Health. Singapore: Springer
Singapore; 2021. p. 205-29.
312.
Vessa B, Perlman B, McGovern PG, Morelli SS. Endocrine disruptors and female fertility: a
review of pesticide and plasticizer effects. F&S Reports. 2022;3(2):86-90.
313.
Wang W, Hafner KS, Flaws JA. In utero bisphenol A exposure disrupts germ cell nest
breakdown and reduces fertility with age in the mouse. Toxicol Appl Pharmacol. 2014;276(2):157-64.
314.
Mahalingam S, Ther L, Gao L, Wang W, Ziv-Gal A, Flaws JA. The effects of in utero bisphenol
A exposure on ovarian follicle numbers and steroidogenesis in the F1 and F2 generations of mice. Reprod
Toxicol. 2017;74:150-7.
315.
Desmarchais A, Téteau O, Papillier P, Jaubert M, Druart X, Binet A, et al. Bisphenol S Impaired
In Vitro Ovine Early Developmental Oocyte Competence. International Journal of Molecular Sciences.
2020;21(4):1238.
44
Supplemental Material
Figure S1: Disability-Adjusted Life Years (DALYs) of worldwide selected non-communicable
diseases in both sexes and all age groups, 1990 - 2017 (Diabetes, urogenital, blood, and
endocrine diseases: data 1990-2016). Data: Global Burden of Disease 2021.
45